合成路线1
该中间体在本合成路线中的序号:
(II) The phenylhydrazone of benzaldehyde (I) is obtained in the usual way, phenylhydrazine (A) with benzaldehyde (B), which by reaction with benzoyl chloride (II) gives (C) and further treatment with HCl in an organic solvent results in the substituted hydrazine hydrochloride (III). Finally, this compound is condensed with levulinic acid (IV) at high temperature.
【1】
Francia, E.; Marin, A. (Uriach & Cia S.A.); Procedimiento de obtencion del acido 1-benzoil-2-metilindol-3-acetico. ES 471436 .
|
【2】
Francia, E.; Garcia Rafanell, J.; Delmetacin. Drugs Fut 1983, 8, 9, 764.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
10498 |
Benzaldehyde;Benzoic aldehyde;Phenylmethanal |
100-52-7 |
C7H6O |
详情 | 详情
|
(A) |
11818 |
Phenyl hydrazine; 1-Phenylhydrazine
|
100-63-0 |
C6H8N2 |
详情 | 详情
|
(I) |
36167 |
benzaldehyde N-phenylhydrazone
|
588-64-7 |
C13H12N2 |
详情 | 详情
|
(II) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(III) |
36169 |
N-phenylbenzohydrazide
|
|
C13H12N2O |
详情 |
详情
|
(IV) |
36170 |
4-oxopentanoic acid
|
123-76-2 |
C5H8O3 |
详情 | 详情
|
(C) |
36168 |
N-phenyl-N'-[(E)-benzylidene]benzohydrazide
|
|
C20H16N2O |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(II) The benzoylation of tyrosine (I) with benzoyl chloride (II) in aqueous NaOH gives O,N-(di-benzoyl)-D,L-tyrosine (III), which by reaction with di-n-propylamine (A) by means of ethyl chlorocarbonate and triethylamine in acetone is converted into O,N-(di-benzoyl)-D,L-tyrosyl-di-n-propylamide (IV). Selective hydrolysis of (IV) with NaOH in methanol - water affords N-benzoyl-D,L-tyrosyl-di-n-propylamide (V), which is finally condensed with 2-(diethylamino)ethyl chloride (VI) by means of sodium methoxide in refluxing toluene.
【1】
Senin; et al.; Activity of derivatives of tyrosine on gastrointestinal motility. Gastrointestinal Motility in Health and Disease. Duthie, H.L. (Ed.); MTP Press Limited, Lancaster 1978, 417-427.
|
【2】
Makovec, F.; Rovati, L.; Senini, P. (Rotta Research Laboratorium SpA); O-Tertiary amino-alkyl-N-benzoyl tyrosil amides. DE 2503992; FR 2259592; GB 1467927; JP 50116442; NL 167683C; US 4004008 .
|
【3】
Serradell, M.N.; de Angelis, L.; Blancafort, P.; Castaner, J.; Tiropramide. Drugs Fut 1982, 7, 6, 413.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
21856 |
N,N-dipropylamine; N-propyl-1-propanamine
|
142-84-7 |
C6H15N |
详情 | 详情
|
(I) |
31970 |
4-Hydroxy-17O-phenylalanine; Hydroxy Phenyl Alanine; DL-tyrosine; 2-Amino-3-(4-hydroxyphenyl)propionic acid; 3-(4-Hydroxyphenyl)alanine; beta-(p-Hydroxyphenyl)alanine; tyrosine
|
556-03-6 |
C9H11NO3 |
详情 | 详情
|
(II) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(III) |
31971 |
N-benzoyl-4-(benzoyloxy)phenylalanine
|
|
C23H19NO5 |
详情 |
详情
|
(IV) |
31972 |
4-[2-(benzoylamino)-3-(dipropylamino)-3-oxopropyl]phenyl benzoate
|
|
C29H32N2O4 |
详情 |
详情
|
(V) |
31973 |
N-[2-(dipropylamino)-1-(4-hydroxybenzyl)-2-oxoethyl]benzamide
|
|
C22H28N2O3 |
详情 |
详情
|
(VI) |
16194 |
2-chloro-N,N-diethyl-1-ethanamine; N-(2-chloroethyl)-N,N-diethylamine
|
100-35-6 |
C6H14ClN |
详情 | 详情
|
合成路线3
该中间体在本合成路线中的序号:
(D) N-bromoacetyl compound (IV) can also be obtained by bromoacetylation of (XV) with bromoacetyl bromide (B) in refluxing benzene affording 4-chloro-N-bromoacetyl-N-(2,2,2-trifluoroethyl)aniline (XVI), followed by a Friedel-Crafts reaction with benzoyl chloride by means of AlCl3.
【1】
Topliss, J.G.; 2-Polyfluoroweralkyl benzophenones. US 3641147 .
|
【2】
Topliss, J.G.; 1-Polyhalogenoalkyl-2-oxo-1,3-dihydro-2H-14-benzodiazepines. US 3429874 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(D) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(B) |
14005 |
2-Bromoacetyl bromide; Bromoacetyl bromide
|
598-21-0 |
C2H2Br2O |
详情 | 详情
|
(IV) |
33849 |
N-(2-benzoyl-4-chlorophenyl)-2-bromo-N-(2,2,2-trifluoroethyl)acetamide
|
|
C17H12BrClF3NO2 |
详情 |
详情
|
(XV) |
33475 |
N-(4-chlorophenyl)-N-(2,2,2-trifluoroethyl)amine; 4-chloro-N-(2,2,2-trifluoroethyl)aniline
|
|
C8H7ClF3N |
详情 |
详情
|
(XVI) |
33852 |
2-bromo-N-(4-chlorophenyl)-N-(2,2,2-trifluoroethyl)acetamide
|
|
C10H8BrClF3NO |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(D) The starting benzophenone (I) can also be obtained in several different ways:
a) By a Friedel-Crafts reaction of p-chloroaniline (X) and benzoyl chloride (D).
b) By reaction of 5-chloroanthranilic acid (XI) with acetic anhydride to the bicyclic compound (XII), which is then submitted to a Grignard reaction with phenylmagnesium bromide (E).
c) By oxidation of 2,3-diphenyl-5-chloroindole (XIII) with CrO3 to the N-benzoylbenzophenone (XIV), followed by debenzoylation with NaOH.
【1】
Topliss, J.G.; 1-Polyhalogenoalkyl-2-oxo-1,3-dihydro-2H-14-benzodiazepines. US 3429874 .
|
【2】
Topliss, J.G.; 2-Polyfluoroweralkyl benzophenones. US 3641147 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(D) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(E) |
17616 |
bromo(phenyl)magnesium; Phenyl Magnesium Bromide
|
100-58-3 |
C6H5BrMg |
详情 | 详情
|
(I) |
10279 |
(2-Amino-5-chlorophenyl)(phenyl)methanone; 2-Amino-5-chlorobenzophenone
|
719-59-5 |
C13H10ClNO |
详情 | 详情
|
(X) |
12034 |
4-Chlorophenylamine; 4-Chloroaniline; p-Chloroaniline
|
106-47-8 |
C6H6ClN |
详情 | 详情
|
(XI) |
10285 |
2-Amino-5-chlorobenzoic acid
|
635-21-2 |
C7H6ClNO2 |
详情 | 详情
|
(XII) |
33853 |
6-chloro-2-methyl-4H-3,1-benzoxazin-4-one
|
|
C9H6ClNO2 |
详情 |
详情
|
(XIII) |
33854 |
5-chloro-2,3-diphenyl-1H-indole
|
|
C20H14ClN |
详情 |
详情
|
(XIV) |
33855 |
N-(2-benzoyl-4-chlorophenyl)benzamide
|
|
C20H14ClNO2 |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(D) The reaction of 4-chloro-N-(2,2,2-trifluoroethyl)aniline (V) with ethyleneimine (C) by means of AlCl3 in benzene affords the N-(2-aminoethyl) compound (VI), which is benzoylated with benzoyl chloride (D) as usual yielding the benzamide (VII). Compound (VII) is cyclized with P2O5 in POCl3 giving 7-chloro-1,2-dihydro-5-phenyl-1-(2,2,2-trifluoroethyl)-3H-1,4-benzodiazepine (VIII), which is finally oxidized with RuO4.
【1】
Topliss, J.G.; Steinman, M.; Alekel, R.; Wong, Y.S.; York, E.E.; 1-Polyfluoroalkylbenzodiazepines. J Med Chem 1973, 16, 12, 1354-60.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(D) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(V) |
33475 |
N-(4-chlorophenyl)-N-(2,2,2-trifluoroethyl)amine; 4-chloro-N-(2,2,2-trifluoroethyl)aniline
|
|
C8H7ClF3N |
详情 |
详情
|
(VI) |
33476 |
N(1)-(4-chlorophenyl)-N(1)-(2,2,2-trifluoroethyl)-1,2-ethanediamine; N-(2-aminoethyl)-N-(4-chlorophenyl)-N-(2,2,2-trifluoroethyl)amine
|
|
C10H12ClF3N2 |
详情 |
详情
|
(VII) |
33850 |
N-[2-[4-chloro(2,2,2-trifluoroethyl)anilino]ethyl]benzamide
|
|
C17H16ClF3N2O |
详情 |
详情
|
(VIII) |
33851 |
7-chloro-5-phenyl-1-(2,2,2-trifluoroethyl)-2,3-dihydro-1H-1,4-benzodiazepine
|
|
C17H14ClF3N2 |
详情 |
详情
|
(C) |
10151 |
Ethyleneimine; Aziridine; Azirane
|
151-56-4 |
C2H5N |
详情 | 详情
|
合成路线6
该中间体在本合成路线中的序号:
The reaction of 3,4-dihydro-1H-2-benzopyran (VII) with benzoyl chloride and ZnCl2 gives benzoic acid 2-[2-(chloromethyl)phenyl]ethyl ester (XIII), which is condensed with hexamethylenetetramine (XIV) yielding the amminium salt (XV). The hydrolysis of (XV) affords 2-(2-benzoyloxyethyl) benzaldehyde (XVI), which is condensed with nitromethane as before to give the nitrostyrene (XVII). The cyclization of (XVII) with FeCl3 and acetyl chloride as before yields 4-(2-benzoyloxyethyl)-3-chloroindolin-2-one (XVIII), which is dechlorinated with hydrazine and Pd/C to the indolinone (XIX). The hydrolysis of (XIX) with NaOH affords 4-(2-hydroxyethyl)indolin-2-one (XX), which is acylated with TsCl giving the tosylate (XXI). Finally, this compound is condensed with dipropylamine (II).
【1】
Hayler, J.D.; et al.; Development of large-scale syntheses or ropinirole in the pursuit of a manufacturing process. Org Process Res Dev 1998, 2, 1, 3.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
|
19273 |
acetyl chloride
|
75-36-5 |
C2H3ClO |
详情 | 详情
|
|
39563 |
nitromethane
|
75-52-5 |
CH3NO2 |
详情 | 详情
|
(II) |
21856 |
N,N-dipropylamine; N-propyl-1-propanamine
|
142-84-7 |
C6H15N |
详情 | 详情
|
(VII) |
34866 |
3,4-dihydro-1H-isochromene
|
493-05-0 |
C9H10O |
详情 | 详情
|
(XIII) |
34872 |
2-(chloromethyl)phenethyl benzoate
|
|
C16H15ClO2 |
详情 |
详情
|
(XIV) |
34873 |
1,3,5,7-tetraazatricyclo[3.3.1.1(3,7)]decane
|
100-97-0 |
C6H12N4 |
详情 | 详情
|
(XV) |
34874 |
1-[2-[2-(benzoyloxy)ethyl]benzyl]-3,5,7-triaza-1-azoniatricyclo[3.3.1.1(3,7)]decane chloride
|
|
C22H27ClN4O2 |
详情 |
详情
|
(XVI) |
34875 |
2-formylphenethyl benzoate
|
|
C16H14O3 |
详情 |
详情
|
(XVII) |
34876 |
2-[(E)-2-nitroethenyl]phenethyl benzoate
|
|
C17H15NO4 |
详情 |
详情
|
(XVIII) |
34877 |
2-(3-chloro-2-oxo-2,3-dihydro-1H-indol-4-yl)ethyl benzoate
|
|
C17H14ClNO3 |
详情 |
详情
|
(XIX) |
34878 |
2-(2-oxo-2,3-dihydro-1H-indol-4-yl)ethyl benzoate
|
|
C17H15NO3 |
详情 |
详情
|
(XX) |
34879 |
4-(2-Hydroxyethyl)indolin-2-one |
139122-19-3 |
C10H11NO2 |
详情 | 详情
|
(XXI) |
34880 |
4-heptanol
|
589-55-9 |
C7H16O |
详情 | 详情
|
合成路线7
该中间体在本合成路线中的序号:
A process for the preparation of taxol has been described:
The acylation of baccatin III (I) with 2,2,2-trichloroethyl chloroformate in pyridine yields the chloroformate (II), which is acylated with cinnamic acid (III) by means of oxalyl chloride of dicyclohexylcarbodiimide to the cinnamate (IV). The oxidative addition of tert-butyl N-chlorocarbamate (V) to (IV) by means of OsO4 in water affords the protected amino hydroxyester (VI), which is deprotected with iodotrimethylsilane in acetonitrile to give the free aminoester (VII). The benzoylation of (VII) with benzoyl chloride in pyridine affords the protected N-benzoyl derivative (VIII), which is finally deprotected by treatment with Zn and acetic acid to eliminate the trichloroethoxycarbonyl group.
【1】
Colin, M.; Guenard, D.; Gueritte-Voegelein, F.; Potier, P. (Aventis SA); Process for the preparation of taxol and 10-deacetyltaxol. US 4857653 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(I) |
10447 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-1,9,15-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
|
C31H38O11 |
详情 |
详情
|
(II) |
10448 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-1,15-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9-[[(2,2,2-trichloroethoxy)carbonyl]oxy]-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
|
C34H39Cl3O13 |
详情 |
详情
|
(III) |
10449 |
(Z)-3-Phenyl-2-propenoic acid
|
621-82-9 |
C9H8O2 |
详情 | 详情
|
(IV) |
10450 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-15-[[(Z)-3-phenyl-2-propenoyl]oxy]-9-[[(2,2,2-trichloroethoxy)carbonyl]oxy]-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
|
C43H45Cl3O14 |
详情 |
详情
|
(VI) |
10451 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-([3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl]oxy)-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-[[(2,2,2-trichloroethoxy)carbonyl]oxy]-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate |
|
C48H56Cl3NO17 |
详情 |
详情
|
(VII) |
10452 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-[(3-amino-2-hydroxy-3-phenylpropanoyl)oxy]-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-[[(2,2,2-trichloroethoxy)carbonyl]oxy]-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
|
C43H48Cl3NO15 |
详情 |
详情
|
(VIII) |
10453 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-[[3-(benzoylamino)-2-hydroxy-3-phenylpropanoyl]oxy]-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-[[(2,2,2-trichloroethoxy)carbonyl]oxy]-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate |
|
C50H52Cl3NO16 |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(IX) A new partial synthesis for taxol has been reported:
The cyclization of N-(4-methoxyphenyl)benzylideneimine (I) with acetoxyacetyl chloride (II) by means of triethylamine in dichloromethane gives cis-3-acetoxy-1-(4-methoxyphenyl)-4-phenylazetidin-2-one (III), which is treated with ceric ammonium nitrate in acetonitrile to afford cis-3-acetoxy-4-phenylazetidin-2-one (IV). Hydrolysis of (IV) with KOH in THF-water yields cis-3-hydroxy-4-phenylazetidin-2-one (V), which is submitted to optical resolution giving the (3R,4S)-isomer (VI). The reaction of (VI) with ethyl vinyl ether (VII) by means of methanesulfonic acid in THF affords (3R,4S)-3-(1-ethoxyethoxy)-4-phenylazetidin-2-one (VIII), which is benzoylated with benzoyl chloride (IX) and butyllithium in hexane to give (X). Opening of the azetidine ring of (X) with KOH in THF-water gives (2R,3S)-3-(benzamido)-2-(1-ethoxyethoxy)propanoic acid (XI), which is cyclized with potassium tert-butoxide and methanesulfonyl chloride to (4S,5R)-5-(1-ethoxyethoxy)-2,4-diphenyl-5,6-dihydro-4H-1,3-oxazin-6-one (XII). Finally, this compound is condensed with 7-O-(triethylsilyl)baccatin III (XIV) [prepared from 10-deacetylbaccatin III (XIII) by successive reaction with triethylsilyl chloride and acetyl chloride] by means of dimethylaminopyridine (DMAP) in pyridine.
【1】
Holton, R.A. (University of Florida); Method for preparation of taxol using an oxazinone. US 5015744 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10455 |
N-(4-Methoxyphenyl)-N-[(Z)-benzylidene]amine; 4-Methoxy-N-[(Z)-benzylidene]aniline
|
783-08-4 |
C14H13NO |
详情 | 详情
|
(II) |
10456 |
Acetoxiacetil chloride; 2-chloro-2-oxoethyl acetate
|
13831-31-7 |
C4H5ClO3 |
详情 | 详情
|
(III) |
10457 |
(3R,4S)-1-(4-methoxyphenyl)-2-oxo-4-phenylazetanyl acetate
|
|
C18H17NO4 |
详情 |
详情
|
(IV) |
10458 |
(3R,4S)-2-oxo-4-phenylazetanyl acetate
|
|
C11H11NO3 |
详情 |
详情
|
(V) |
63030 |
cis-3-Hydroxy-4-phenyl-2-azetanone; (3R*,4S*)-3-Hydroxy-4-phenyl-2-azetanone
|
|
C9H9NO2 |
详情 |
详情
|
(VI) |
10459 |
(3R,4S)-3-Hydroxy-4-phenyl-2-azetanone
|
|
C9H9NO2 |
详情 |
详情
|
(VII) |
18762 |
1-Ethoxyethylene; Ethyl vinyl ether;Ethoxyethene |
109-92-2 |
C4H8O |
详情 | 详情
|
(VIII) |
10462 |
(3R,4S)-3-(1-Ethoxyethoxy)-4-phenyl-2-azetanone
|
|
C13H17NO3 |
详情 |
详情
|
(IX) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(X) |
10464 |
(3R,4S)-1-Benzoyl-3-(1-ethoxyethoxy)-4-phenyl-2-azetanone
|
|
C20H21NO4 |
详情 |
详情
|
(XI) |
10465 |
(2R,3S)-3-(Benzoylamino)-2-(1-ethoxyethoxy)-3-phenylpropionic acid
|
|
C20H23NO5 |
详情 |
详情
|
(XII) |
10466 |
(4S,5R)-5-(1-Ethoxyethoxy)-2,4-diphenyl-4,5-dihydro-6H-1,3-oxazin-6-one
|
|
C20H21NO4 |
详情 |
详情
|
(XIII) |
10467 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-(acetoxy)-1,9,12,15-tetrahydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
32981-86-5 |
C29H36O10 |
详情 | 详情
|
(XIV) |
10468 |
(1S,2S,3R,4S,7R,9R,10S,12R,15S)-4,12-bis(acetoxy)-1,15-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9-[(triethylsilyl)oxy]-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
|
C37H52O11Si |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(XIV) The synthesis of tritium-labeled taxol [3''-3H]-taxol has been described:
The reaction of baccatin III (I) with chlorotriethylsilane in pyridine gives the protected compound (II), which is condensed with cis-1-benzoyl-4-(3-bromophenyl)-3-(triethylsilyloxy)azetidin-2-one (III) by means of butyllithium in THF, yielding 3''-bromo-2',7-bis-O-(triethylsilyl)taxol (IV). The deprotection of (IV) with pyridine and 48% HF in THF affords 3''-bromotaxol (V), which is finally debrominated with tritium by means of Pd/C and triethylamine in THF.
The starting azetidinone (III) is obtained as follows: The condensation of 3-bromobenzaldehyde (VI) with 4-methoxyaniline (VII) in refluxing benzene gives the enamine (VIII), which is cyclized with acetoxyacetyl chloride (IX) by means of triethylamine in dichloromethane, yielding cis-3-acetoxy-4-(3-bromophenyl)-1-(4-methoxyphenyl)azetidin-2-one (X). The reaction of (X) with ceric ammonium nitrate (CAN) in acetonitrile affords cis-3-acetoxy-4-(3-bromophenyl)azetidin-2-one (XI), which is deacetylated with KOH in THF-water giving cis-4-(3-bromophenyl)-3-hydroxyazetidin-2-one (XII). The silylation of (XII) with chlorotriethylsilane in pyridine yields cis-4-(3-bromophenyl)-3-(triethylsilyloxy)azetidin-2-one (XIII), which is finally benzoylated with benzoyl chloride (XIV) and butyllithium in THF to afford the desired azetidinone (III).
【1】
Taylor, G.F.; Thornton, S.S.; Tallent, C.R.; Kepler, J.A.; Synthesis of [3''-3H]taxol and [13-3H]taxol. J Label Compd Radiopharm 1993, 33, 6, 501.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10447 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-1,9,15-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
|
C31H38O11 |
详情 |
详情
|
(II) |
10473 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-1,15-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9-[(triethylsilyl)oxy]-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
|
C37H52O11Si |
详情 |
详情
|
(III) |
10474 |
(3R,4S)-1-Benzoyl-4-(3-bromophenyl)-3-[(triethylsilyl)oxy]-2-azetidinone
|
|
C22H26BrNO3Si |
详情 |
详情
|
(IV) |
10475 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-([(2R,3S)-3-(benzoylamino)-3-(3-bromophenyl)-2-[(triethylsilyl)oxy]propanoyl]oxy)-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-[(triethylsilyl)oxy]-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate |
|
C59H78BrNO14Si2 |
详情 |
详情
|
(V) |
10476 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-[[(2R,3S)-3-(benzoylamino)-3-(3-bromophenyl)-2-hydroxypropanoyl]oxy]-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
|
C47H50BrNO14 |
详情 |
详情
|
(VI) |
10477 |
3-Bromobenzaldehyde; m-Bromobenzaldehyde
|
3132-99-8 |
C7H5BrO |
详情 | 详情
|
(VII) |
10478 |
p-Anisidine; 4-Methoxyaniline; 4-Methoxyphenylamine
|
104-94-9 |
C7H9NO |
详情 | 详情
|
(VIII) |
10479 |
N-[(Z)-(3-Bromophenyl)methylidene]-N-(4-methoxyphenyl)amine; N-[(Z)-(3-Bromophenyl)methylidene]-4-methoxyaniline
|
|
C14H12BrNO |
详情 |
详情
|
(IX) |
10456 |
Acetoxiacetil chloride; 2-chloro-2-oxoethyl acetate
|
13831-31-7 |
C4H5ClO3 |
详情 | 详情
|
(X) |
10481 |
(2S,3R)-2-(3-bromophenyl)-1-(4-methoxyphenyl)-4-oxoazetanyl acetate
|
|
C18H16BrNO4 |
详情 |
详情
|
(XI) |
10482 |
(2S,3R)-2-(3-bromophenyl)-4-oxoazetanyl acetate
|
|
C11H10BrNO3 |
详情 |
详情
|
(XII) |
10483 |
(3R,4S)-4-(3-Bromophenyl)-3-hydroxy-2-azetanone
|
|
C9H8BrNO2 |
详情 |
详情
|
(XIII) |
10484 |
(3R,4S)-4-(3-Bromophenyl)-3-[(triethylsilyl)oxy]-2-azetanone
|
|
C15H22BrNO2Si |
详情 |
详情
|
(XIV) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
合成路线10
该中间体在本合成路线中的序号:
(XI) A new partial synthesis of taxol has been described: The esterification of (1S,2R)-2-phenylcyclohexanol (I) with benzyloxyacetyl chloride (II) gives the corresponding chiral ester (III), which is deprotected by hydrogenolysis to the hydroxy ester (IV). Silylation of (IV) with triisopropylsilyl chloride affords the silylated ester (V), which is cyclized with trimethylsilylbenzaldimine (VI) [obtained from benzaldehyde (VII) and hexamethyldisilazane (HMSA)] by means of butyllithium in THF giving (3R,4S)-3-(triisopropylsilyloxy)-4-phenylazetidin-2-one (VIII). The deprotection of (VIII) with tetrabutylammonium fluoride affords (3R,4S)-3-hydroxy-4-phenylazetidin-2-one (IX), which is treated with ethyl vinyl ether to give the 1-ethoxyethyl ether (X). The benzoylation of (X) with benzoyl chloride (XI) by means of dimethylaminopyridine and triethylamine yields (3R,4S)-1-benzoyl-3-(1-ethoxyethoxy)-4-phenylazetidin-2-one (XII), which is condensed with 7-O-(triethylsilyl)baccatin III (XIII) by means of NaH in THF, affording 2'-O-(1-ethoxyethyl)-7-O-(triethylsilyl)taxol (XIV). Finally, this compound is deprotected with HCl in ethanol.
【1】
Habus, I.; Zhao, M.; Brigaud, T.; Zucco, M.; Ojima, I.; Sun, C.M.; Park, Y.H.; New and efficient approaches to the semisynthesis of taxol and its C-13 side chain analogs by means of beta-lactam synthon method. Tetrahedron 1992, 48, 34, 6985.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10492 |
(1S,2R)-(+)-trans-2-Phenyl-1-cyclohexanol; (1S,2R)-2-Phenylcyclohexanol
|
2362-61-0 |
C12H16O |
详情 | 详情
|
(II) |
10493 |
2-(Benzyloxy)acetyl chloride; Benzyloxyacetyl chloride
|
19810-31-2 |
C9H9ClO2 |
详情 | 详情
|
(III) |
10494 |
(1S,2R)-2-phenylcyclohexyl 2-(benzyloxy)acetate
|
|
C21H24O3 |
详情 |
详情
|
(IV) |
10495 |
(1S,2R)-2-phenylcyclohexyl 2-hydroxyacetate
|
|
C14H18O3 |
详情 |
详情
|
(V) |
10496 |
(1S,2R)-2-phenylcyclohexyl 2-(triisopropylsilyl)acetate
|
|
C23H38O2Si |
详情 |
详情
|
(VI) |
10507 |
Trimethyl-N-[(E)-benzylidene]silanamine; N-[(E)-Benzylidene]-N-(trimethylsilyl)amine
|
17599-61-0 |
C10H15NSi |
详情 | 详情
|
(VII) |
10498 |
Benzaldehyde;Benzoic aldehyde;Phenylmethanal |
100-52-7 |
C7H6O |
详情 | 详情
|
(VIII) |
10499 |
(3R,4S)-4-Phenyl-3-[(triisopropylsilyl)oxy]-2-azetanone
|
|
C18H29NO2Si |
详情 |
详情
|
(IX) |
10459 |
(3R,4S)-3-Hydroxy-4-phenyl-2-azetanone
|
|
C9H9NO2 |
详情 |
详情
|
(X) |
10462 |
(3R,4S)-3-(1-Ethoxyethoxy)-4-phenyl-2-azetanone
|
|
C13H17NO3 |
详情 |
详情
|
(XI) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(XII) |
10464 |
(3R,4S)-1-Benzoyl-3-(1-ethoxyethoxy)-4-phenyl-2-azetanone
|
|
C20H21NO4 |
详情 |
详情
|
(XIII) |
10473 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-1,15-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9-[(triethylsilyl)oxy]-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
|
C37H52O11Si |
详情 |
详情
|
(XIV) |
10505 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-[[(2R,3S)-3-(benzoylamino)-2-(1-ethoxyethoxy)-3-phenylpropanoyl]oxy]-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-[(triethylsilyl)oxy]-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate |
|
C57H73NO15Si |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
A new synthesis of paclitaxel has been reported: The cyclization of the 4-methoxyphenylimine of benzaldehyde (I) with acetoxyacetyl chloride (II) by means of triethylamine gives cis-3-acetoxy-1-(4-methoxyphenyl)-4-phenylazetidin-2-one (III), which is treated with ceric ammonium nitrate to afford cis-3-acetoxy-4-phenylazetidin-2-one (IV). The hydrolysis of (IV) with KOH in THF/water affords the corresponding hydroxy compound (V), which is submitted to optical resolution by crystallization of the 2-methoxy-2-[2-(trifluoromethyl)phenyl]acetic esters. The (3R,4S)-regioisomer (VI) is protected with ethyl vinyl ether, giving the 1-ethoxyethyl derivative (VII), which is benzoylated with benzoyl chloride and butyllithium to afford (3R,4S)-1-benzoyl-3-(1-ethoxyethoxy)-4-phenylazetidin-2-one (VIII). The condensation of (VIII) with baccatin III (IX) by means of dimethylaminopyridine (DMAP) in pyridine yields the protected paclitaxel derivative (X), which is finally deprotected with HCl in ethanol/water.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(I) |
10455 |
N-(4-Methoxyphenyl)-N-[(Z)-benzylidene]amine; 4-Methoxy-N-[(Z)-benzylidene]aniline
|
783-08-4 |
C14H13NO |
详情 | 详情
|
(II) |
10456 |
Acetoxiacetil chloride; 2-chloro-2-oxoethyl acetate
|
13831-31-7 |
C4H5ClO3 |
详情 | 详情
|
(III) |
10457 |
(3R,4S)-1-(4-methoxyphenyl)-2-oxo-4-phenylazetanyl acetate
|
|
C18H17NO4 |
详情 |
详情
|
(IV) |
10458 |
(3R,4S)-2-oxo-4-phenylazetanyl acetate
|
|
C11H11NO3 |
详情 |
详情
|
(V) |
63030 |
cis-3-Hydroxy-4-phenyl-2-azetanone; (3R*,4S*)-3-Hydroxy-4-phenyl-2-azetanone
|
|
C9H9NO2 |
详情 |
详情
|
(VI) |
10459 |
(3R,4S)-3-Hydroxy-4-phenyl-2-azetanone
|
|
C9H9NO2 |
详情 |
详情
|
(VII) |
10462 |
(3R,4S)-3-(1-Ethoxyethoxy)-4-phenyl-2-azetanone
|
|
C13H17NO3 |
详情 |
详情
|
(VIII) |
10464 |
(3R,4S)-1-Benzoyl-3-(1-ethoxyethoxy)-4-phenyl-2-azetanone
|
|
C20H21NO4 |
详情 |
详情
|
(IX) |
10473 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-1,15-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9-[(triethylsilyl)oxy]-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
|
C37H52O11Si |
详情 |
详情
|
(X) |
10505 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-[[(2R,3S)-3-(benzoylamino)-2-(1-ethoxyethoxy)-3-phenylpropanoyl]oxy]-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-[(triethylsilyl)oxy]-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate |
|
C57H73NO15Si |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(XIII) A new synthesis of [14C]-labeled paclitaxel has been published: The protection of L-threonine methyl ester (I) with tert-butoxydiphenylchlorosilane (BPS-Cl) gives the compound (II), which is condensed with [14C]-labeled benzaldehyde (III), yielding the imine (IV). The cyclization of (IV) with acetoxyacetyl chloride (V) by means of triethylamine affords the azetidinone (VI), which is deprotected with tetrabutylammonium fluoride to the hydroxy ester (VII). The dehydration of (VII) with p-toluenesulfonyl chloride and triethylamine affords the unsaturated ester (VIII), which by ozonolysis is converted to the oxalimide (IX). Elimination of the oxalyl group with hydrazine gives the labeled azetidinone (X), which is deacetylated to the hydroxyazetidinone (XI) and protected with triethylchlorosilane (TES-Cl) to (XII). The benzoylation of (XII) with benzoyl chloride (XIII) and dimethylaminopyridine (DMAP) yields the corresponding benzoylated compound (XIV), which is then condensed with triethylsilyl-baccatin III (XV) by means of butyllithium to afford silylated labeled paclitaxel (XVI). Finally, this compound is deprotected with HCl. The intermediate silylated baccatin III (XV) is obtained from paclitaxel (XVII) by hydrogenolysis with NaBH4 to baccatin III (XVIII) and silylation with triethylsilyl chloride to (XV).
【1】
Walker, D.G.; Swigor, J.E.; Standridge, R.T.; Synthesis of paclitaxel-C3'-C-14. J Label Compd Radiopharm 1995, 36, 5, 479.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10674 |
(2S,3R)-3-Hydroxy-1-methoxy-1-oxo-2-butanaminium chloride
|
|
C5H12ClNO3 |
详情 |
详情
|
(II) |
10675 |
methyl (2S,3R)-2-amino-3-methoxybutanoate
|
|
C21H29NO4Si |
详情 |
详情
|
(III) |
10498 |
Benzaldehyde;Benzoic aldehyde;Phenylmethanal |
100-52-7 |
C7H6O |
详情 | 详情
|
(III) |
44663 |
benzaldehyde
|
|
C7H6O |
详情 |
详情
|
(IV) |
10677 |
methyl (2S,3R)-3-methoxy-2-[[(E)-benzylidene]amino]butanoate
|
|
C28H33NO4Si |
详情 |
详情
|
(IV) |
44664 |
methyl (2S,3R)-3-methoxy-2-[[(E)-benzylidene]amino]butanoate
|
|
C13H17NO3 |
详情 |
详情
|
(V) |
10456 |
Acetoxiacetil chloride; 2-chloro-2-oxoethyl acetate
|
13831-31-7 |
C4H5ClO3 |
详情 | 详情
|
(VI) |
10679 |
methyl (2S,3R)-2-[(3R,4S)-3-(acetoxy)-2-oxo-4-phenylazetidinyl]-3-methoxybutanoate
|
|
C32H37NO7Si |
详情 |
详情
|
(VI) |
44665 |
methyl (2S,3R)-2-[(3R,4S)-3-(acetoxy)-2-oxo-4-phenylazetidinyl]-3-methoxybutanoate
|
|
C17H21NO6 |
详情 |
详情
|
(VII) |
10680 |
methyl (2S,3R)-2-[(3R,4S)-3-(acetoxy)-2-oxo-4-phenylazetidinyl]-3-hydroxybutanoate
|
|
C16H19NO6 |
详情 |
详情
|
(VII) |
44666 |
methyl (2S,3R)-2-[(3R,4S)-3-(acetoxy)-2-oxo-4-phenylazetidinyl]-3-hydroxybutanoate
|
|
C16H19NO6 |
详情 |
详情
|
(VIII) |
10681 |
methyl (Z)-2-[(3R,4S)-3-(acetoxy)-2-oxo-4-phenylazetidinyl]-2-butenoate
|
|
C16H17NO5 |
详情 |
详情
|
(VIII) |
44667 |
methyl (Z)-2-[(3R,4S)-3-(acetoxy)-2-oxo-4-phenylazetidinyl]-2-butenoate
|
|
C16H17NO5 |
详情 |
详情
|
(IX) |
10682 |
methyl 2-[(3R,4S)-3-(acetoxy)-2-oxo-4-phenylazetidinyl]-2-oxoacetate
|
|
C14H13NO6 |
详情 |
详情
|
(IX) |
44668 |
methyl 2-[(3R,4S)-3-(acetoxy)-2-oxo-4-phenylazetidinyl]-2-oxoacetate
|
|
C14H13NO6 |
详情 |
详情
|
(X) |
10683 |
methyl 2-[(3R,4S)-3-(acetoxy)-2-oxo-4-phenylazetidinyl]-2-oxoacetate
|
|
C14H13NO6 |
详情 |
详情
|
(X) |
44669 |
(3R,4S)-2-oxo-4-phenylazetidinyl acetate
|
|
C11H11NO3 |
详情 |
详情
|
(XI) |
10459 |
(3R,4S)-3-Hydroxy-4-phenyl-2-azetanone
|
|
C9H9NO2 |
详情 |
详情
|
(XI) |
44670 |
(3R,4S)-3-hydroxy-4-phenyl-2-azetidinone
|
|
C9H9NO2 |
详情 |
详情
|
(XII) |
10685 |
(3R,4S)-4-Phenyl-3-[(triethylsilyl)oxy]-2-azetidinone
|
|
C15H23NO2Si |
详情 |
详情
|
(XII) |
44673 |
(3R,4S)-3-hydroxy-4-phenyl-2-azetidinone
|
|
C9H9NO2 |
详情 |
详情
|
(XIII) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(XIV) |
10687 |
(3R,4S)-1-Benzoyl-3-hydroxy-4-phenyl-2-azetidinone
|
|
C16H13NO3 |
详情 |
详情
|
(XIV) |
44671 |
(3R,4S)-1-benzoyl-3-hydroxy-4-phenyl-2-azetidinone
|
|
C16H13NO3 |
详情 |
详情
|
(XV) |
10473 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-1,15-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9-[(triethylsilyl)oxy]-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
|
C37H52O11Si |
详情 |
详情
|
(XVI) |
10689 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-([(2R,3S)-3-(benzoylamino)-3-phenyl-2-[(triethylsilyl)oxy]propanoyl]oxy)-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-[(triethylsilyl)oxy]-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate |
n/a |
AB |
详情 | 详情
|
(XVI) |
44672 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-[[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoyl]oxy]-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
|
C47H51NO14 |
详情 |
详情
|
(XVII) |
10595 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-[[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoyl]oxy]-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
33069-62-4 |
C47H51NO14 |
详情 | 详情
|
(XVIII) |
10447 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-1,9,15-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
|
C31H38O11 |
详情 |
详情
|
合成路线13
该中间体在本合成路线中的序号:
A new method for the synthesis of paclitaxel side chain has been developed: The esterification of (S)-phenylglycine (I) with SOCl2 and methanol gives the corresponding methyl ester (II), which is acylated with benzoyl chloride and pyridine to the benzoyl derivative (III). The reduction of (III) with dibutylaluminum hydride (DIBAL) in toluene yields the corresponding aldehyde (IV), which is condensed with 2-(trimethylsilyl)thiazole (V) by means of tetrabutylammonium fluoride (TBAF) to afford the (1R,2S)-N-[2-hydroxy-1-phenyl-2-(2-thiazolyl)ethyl]benzamide (VI) with a 95% enantiomeric purity. The cyclization of (VI) with 2,2-dimethoxypropane (VII) catalyzed by camphosulfonic acid (CSA) gives (4S,5R)-3-benzoyl-2,2-dimethyl-4-phenyl-5-(2-thiazolyl)oxazolidine (VIII), which is treated with methyl trifluoromethanesulfonate to afford (4S,5R)-3-benzoyl-2,2-dimethyl-4-phenyloxazolidine-5-carbaldehyde (IX). Finally, this compound is oxidized with KMnO4 in tert-butanol/aqueous potassium phosphate buffer to yield (4S,5R)-3-benzoyl-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid (X), the side chain of paclitaxel suitably protected.
【1】
Semola, T.; Dondoni, A.; Perrone, D.; Synthesis of Taxol and Taxotere side chains by 2-(trimethylsilyl)thiazole based homologation of L-phenylglycine. Synthesis 1995, 2, 2, 181.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(I) |
10716 |
(2S)-2-Amino-2-phenylethanoic acid; L-(+)-alpha-Phenylglycine
|
2935-35-5 |
C8H9NO2 |
详情 | 详情
|
(II) |
10717 |
methyl (2S)-2-amino-2-phenylethanoate
|
|
C9H11NO2 |
详情 |
详情
|
(III) |
10718 |
methyl (2S)-2-(benzoylamino)-2-phenylethanoate
|
|
C16H15NO3 |
详情 |
详情
|
(IV) |
10719 |
N-[(1S)-2-Oxo-1-phenylethyl]benzamide
|
|
C15H13NO2 |
详情 |
详情
|
(V) |
10720 |
2-(Trimethylsilyl)-1,3-thiazole
|
79265-30-8 |
C6H11NSSi |
详情 | 详情
|
(VI) |
10721 |
N-[(1S,2R)-2-Hydroxy-1-phenyl-2-(1,3-thiazol-2-yl)ethyl]benzamide
|
|
C18H16N2O2S |
详情 |
详情
|
(VII) |
10722 |
1-Methoxy-1-methylethyl methyl ether; 2,2-Dimethoxypropane
|
77-76-9 |
C5H12O2 |
详情 | 详情
|
(VIII) |
10723 |
[(4S,5R)-2,2-Dimethyl-4-phenyl-5-(1,3-thiazol-2-yl)-1,3-oxazolidin-3-yl](phenyl)methanone
|
|
C21H20N2O2S |
详情 |
详情
|
(IX) |
10724 |
(4S,5R)-3-Benzoyl-2,2-dimethyl-4-phenyl-1,3-oxazolidine-5-carbaldehyde
|
|
C19H19NO3 |
详情 |
详情
|
(X) |
10725 |
(4S,5R)-3-Benzoyl-2,2-dimethyl-4-phenyl-1,3-oxazolidine-5-carboxylic acid
|
|
C19H19NO4 |
详情 |
详情
|
合成路线14
该中间体在本合成路线中的序号:
(V) Three partial syntheses of Taxol are described starting from Taxol analogues such as Taxol C or Taxol B (cephalomannine):
1) The reaction of Taxol C (I) with triethylsilyl chloride (TES-Cl) in pyridine gives the bis(triethylsilyl) derivative (II), which by reduction with zirconocene chloride hydride [bis(cyclopentadienyl)zirconium chloride hydride] in dry THF yields compound (III). The hydrolytic cleavage of (III) with simultaneous desilylation by means of HCl in ethanol affords [2aR-[2aalpha,4beta,4abeta,6beta,9alpha(2R,3S),11beta,12alpha,12aalpha,12balpha]]-6,12b-diacetoxy-9-(3-amino-2-hydroxy-3-phenylpropionyloxy)-1 2-benzoyloxy-4,11-dihydroxy-4a,8,13,13-tetramethyl-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benz[1,2-b]oxet-5-one (IV) with a free amino group, which is benzoylated with benzoyl chloride (V) and pyridine to Taxol.
【1】
Young, T.H. (Hauser, Inc.); Preparation of Taxol and docetaxel through primary amines. EP 0852581; WO 9623780 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10726 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-[[(2R,3S)-3-(hexanoylamino)-2-hydroxy-3-phenylpropanoyl]oxy]-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
|
C46H57NO14 |
详情 |
详情
|
(II) |
10727 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-[[(2R,3S)-3-(hexanoylamino)-2-methoxy-3-phenylpropanoyl]oxy]-1-hydroxy-9-methoxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
|
C48H61NO14 |
详情 |
详情
|
(III) |
10728 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-([(2R,3S)-3-[(E)hexylideneamino]-2-methoxy-3-phenylpropanoyl]oxy)-1-hydroxy-9-methoxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
|
C48H61NO13 |
详情 |
详情
|
(IV) |
10729 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-[[(2R,3S)-3-amino-2-hydroxy-3-phenylpropanoyl]oxy]-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
|
C40H47NO13 |
详情 |
详情
|
(V) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
合成路线15
该中间体在本合成路线中的序号:
(V) The benzoylation of (IV) with benzoyl chloride (V) and triethylamine in ethyl acetate affords the fully protected Taxol derivative (VI), which is desillylated with HF in acetonitrile giving the partially protected Taxol derivative (VII). Finally, this compound is fully deprotected by hydrogenation with H2 over Pd/C in isopropanal at 40 atm to give taxol.
【1】
Sisti, N.J.; Swindell, C.S.; Chander, M.C. (NaPro BioTherapeutics, Inc.); Paclitaxel synthesis from precursor compounds and methods of producing the same. US 5675025 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IV) |
10729 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-[[(2R,3S)-3-amino-2-hydroxy-3-phenylpropanoyl]oxy]-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
|
C40H47NO13 |
详情 |
详情
|
(V) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(VI) |
10746 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-([(2R,3S)-3-(benzoylamino)-2-[(benzyloxy)methoxy]-3-phenylpropanoyl]oxy)-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-[(triethylsilyl)oxy]-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate |
|
C61H73NO15Si |
详情 |
详情
|
(VII) |
10747 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-([(2R,3S)-3-(benzoylamino)-2-[(benzyloxy)methoxy]-3-phenylpropanoyl]oxy)-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
|
C55H59NO15 |
详情 |
详情
|
合成路线16
该中间体在本合成路线中的序号:
(IX) A new synthesis of paclitaxel has been reported: The esterification of (2R,3S)-2,3-epoxy-3-phenylpropionic acid (I) with 2-(trimethylsilyl)ethanol (II) by means of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) in hot toluene gives the expected ester (III), which is treated with LiBr in acetic acid to yield the (2R,3R)-3-bromo-2-hydroxy ester (IV). The reaction of (IV) with sodium azide in hot DMF affords the corresponding azido derivative (V), which is reduced with ammonium formate or H2 over Pd/C giving the (2R,3S)-3-amino-2-hydroxy ester (VI). The amidation of (VI) with benzyl chloroformate (VII) yields the corresponding benzyloxycarbonylamino compound (VIII), which is esterified with benzoyl chloride (IX) and triethylamine affording (2R,3S)-2-(benzoyloxy)-3-(benzyloxycarbonylamino)-3-phenylpropionic acid 2-(trimethylsilyl)ethyl ester (X). The condensation of the ester (X) with 7-O-(triethylsilyl)baccatin (XI) by means of 4-(1-pyrrolidinyl)-piperidine (4-PP) and dicyclohexylcarbodiimide (DCC) in hot toluene gives the mixed ester (XII). Finally, this compound is hydrogenated with ammonium formate and Pd/C to obtain a free amino group to which the benzoyl group of the a-position is transferred by a treatment with formic acid yielding pure paclitaxel.
【1】
Gao, Y.; Zepp, C.M. (Sepracor Inc.); Taxol process and cpds.. US 5760251 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
20322 |
(2R,3S)-3-phenyl-2-oxiranecarboxylic acid
|
|
C9H8O3 |
详情 |
详情
|
(II) |
20323 |
2-(trimethylsilyl)-1-ethanol
|
2916-68-9 |
C5H14OSi |
详情 | 详情
|
(III) |
20324 |
2-(trimethylsilyl)ethyl (2R,3S)-3-phenyl-2-oxiranecarboxylate
|
|
C14H20O3Si |
详情 |
详情
|
(IV) |
20325 |
2-(trimethylsilyl)ethyl (2S,3S)-3-bromo-2-hydroxy-3-phenylpropanoate
|
|
C14H21BrO3Si |
详情 |
详情
|
(V) |
20326 |
2-(trimethylsilyl)ethyl (2R,3S)-3-azido-2-hydroxy-3-phenylpropanoate
|
|
C14H21N3O3Si |
详情 |
详情
|
(VI) |
20327 |
2-(trimethylsilyl)ethyl (2R,3S)-3-amino-2-hydroxy-3-phenylpropanoate
|
|
C14H23NO3Si |
详情 |
详情
|
(VII) |
10101 |
Benzyloxycarbonyl chloride; Benzyl chloroformate; 1-[[(Chlorocarbonyl)oxy]methyl]benzene
|
501-53-1 |
C8H7ClO2 |
详情 | 详情
|
(VIII) |
20329 |
2-(trimethylsilyl)ethyl (2R,3S)-3-[[(benzyloxy)carbonyl]amino]-2-hydroxy-3-phenylpropanoate
|
|
C22H29NO5Si |
详情 |
详情
|
(IX) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(X) |
20331 |
(1R,2S)-2-[[(benzyloxy)carbonyl]amino]-2-phenyl-1-[[2-(trimethylsilyl)ethoxy]carbonyl]ethyl benzoate
|
|
C29H33NO6Si |
详情 |
详情
|
(XI) |
20332 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-1,15-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9-[(triethylsilyl)oxy]-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
|
C37H52O11Si |
详情 |
详情
|
(XII) |
20333 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-[((2R,3S)-2-(benzoyloxy)-3-[[(benzyloxy)carbonyl]amino]-3-phenylpropanoyl)oxy]-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-[(triethylsilyl)oxy]-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate |
|
C61H71NO16Si |
详情 |
详情
|
合成路线17
该中间体在本合成路线中的序号:
(VII) The reaction of baccatine III (I) with trichloroacetyl chloride in pyridine gives 7-O-(trichloroacetyl)baccatine III (II), which is condensed with 2,3-epoxy-3-phenylpropionic acid (III) by means of DCC and DMAP in toluene to yield the ester (IV). Opening of the epoxide ring of (IV) by means of sodium azide and methyl formate in methanol affords the expected hydroxy azide (V), which is reduced with PPh3 in dichloromethane/water to provide the corresponding amino derivative (VI). Finally, the amino group of (VI) is benzoylated with benzoyl chloride (VII) and NaHCO3 in ethyl acetate/water to furnish the target paclitaxel.
【1】
Bombardelli, E.; Pontiroli, A.; Battaglia, A.; Dambruoso, P.; Guerrini, A. (Indena SpA); A process for the preparation of paclitaxel. WO 0246177 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10447 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-1,9,15-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
|
C31H38O11 |
详情 |
详情
|
(II) |
38901 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-1,15-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9-[(2,2,2-trichloroacetyl)oxy]-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
|
C33H37Cl3O12 |
详情 |
详情
|
(III) |
23891 |
(2R,3R)-3-phenyl-2-oxiranecarboxylic acid
|
|
C9H8O3 |
详情 |
详情
|
(IV) |
54903 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-2-(benzoyloxy)-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-[(2,2,2-trichloroacetyl)oxy]-6-oxatetracyclo[11.3.1.0~3,10~.0~4,7~]heptadec-13-en-15-yl (2R,3R)-3-phenyl-2-oxiranecarboxylate
|
|
C42H43Cl3O14 |
详情 |
详情
|
(V) |
54904 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-15-{[(2R,3S)-3-azido-2-hydroxy-3-phenylpropanoyl]oxy}-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0~3,10~.0~4,7~]heptadec-13-en-2-yl benzoate
|
|
C40H45N3O13 |
详情 |
详情
|
(VI) |
10729 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-[[(2R,3S)-3-amino-2-hydroxy-3-phenylpropanoyl]oxy]-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
|
C40H47NO13 |
详情 |
详情
|
(VII) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
合成路线18
该中间体在本合成路线中的序号:
(V) The Grignard reaction of phenylmagnesium bromide (I) with 11C labeled CO2 (II) in THF gives the radiolabeled benzoic acid (III), which is treated with phthaloyl dichloride (IV) in the same solvent to yield radiolabeled benzoyl chloride (V). Finally, this compound is treated with N-debenzoylated paclitaxel (VI) in acetonitrile to afford the target radiolabeled paclitaxel.
【1】
Ravert, H.T.; et al.; Radiosynthesis of [11C]paclitaxel. J Label Compd Radiopharm 2002, 45, 6, 471.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17616 |
bromo(phenyl)magnesium; Phenyl Magnesium Bromide
|
100-58-3 |
C6H5BrMg |
详情 | 详情
|
(III) |
10202 |
Benzoic acid
|
65-85-0 |
C7H6O2 |
详情 | 详情
|
(III) |
55347 |
benzoic acid
|
|
C7H6O2 |
详情 |
详情
|
(IV) |
23811 |
phthaloyl dichloride;1,2-Benzenedicarbonyl dichloride;o-Phthaloyl chloride |
88-95-9 |
C8H4Cl2O2 |
详情 | 详情
|
(V) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(V) |
55348 |
benzoyl chloride
|
|
C7H5ClO |
详情 |
详情
|
(VI) |
10729 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-[[(2R,3S)-3-amino-2-hydroxy-3-phenylpropanoyl]oxy]-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
|
C40H47NO13 |
详情 |
详情
|
合成路线19
该中间体在本合成路线中的序号:
(XI) The reaction of (2R,3S)-phenylisoserine (I) with 2-propynyl chloroformate (II) in aq. NaHCO3 gives the N-acylated compound (III), which is treated with diazomethane in ethyl ether (CDI and methanol) to yield the corresponding methyl ester (IV). The reaction of (IV) with 2-methoxypropene (V) and pyridinium p-toluenesulfonate in toluene affords the oxazolidine (VI), which is treated with LiOH in water to provide the oxazolidine-5-carboxylic acid (VII). The esterification of 7-O-(trichloroethoxycarbonyl)baccatin (VIII) with acid (VII) by means of DCC in toluene gives the corresponding ester (IX), which is treated with ammonium tetrathiomolybdate to cleave the oxazolidine ring and yield the 3-amino-2-hydroxypropionyl ester (X). The reaction of (X) with benzoyl chloride (XI) and NaHCO3 in ethyl acetate affords the expected benzamido derivative (XII), which is finally deprotected by means of Zn and AcOH to afford the target paclitaxel.
【1】
Sharma, A.P.; Sarkar, S. (Dabur India Ltd.); Method of preparation of paclitaxel (Taxol) using 3-(alk-2-ynyloxy)carbonyl-5-oxazolidine carboxylic acid. WO 0266448 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
54908 |
(2R,3S)-3-amino-2-hydroxy-3-phenylpropanoic acid
|
136561-53-0 |
C9H11NO3 |
详情 | 详情
|
(II) |
55690 |
Propargyl chloroformate
|
|
C4H3ClO2 |
详情 |
详情
|
(III) |
55691 |
(2R,3S)-2-hydroxy-3-phenyl-3-{[(2-propynyloxy)carbonyl]amino}propanoic acid
|
|
C13H13NO5 |
详情 |
详情
|
(IV) |
55692 |
methyl (2R,3S)-2-hydroxy-3-phenyl-3-{[(2-propynyloxy)carbonyl]amino}propanoate
|
|
C14H15NO5 |
详情 |
详情
|
(V) |
17354 |
isopropenyl methyl ether; 2-methoxy-1-propene
|
116-11-0 |
C4H8O |
详情 | 详情
|
(VI) |
55693 |
5-methyl 3-(2-propynyl) (4S,5R)-2,2-dimethyl-4-phenyl-1,3-oxazolidine-3,5-dicarboxylate
|
|
C17H19NO5 |
详情 |
详情
|
(VII) |
55694 |
(4S,5R)-2,2-dimethyl-4-phenyl-3-[(2-propynyloxy)carbonyl]-1,3-oxazolidine-5-carboxylic acid
|
|
C16H17NO5 |
详情 |
详情
|
(VIII) |
10448 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-1,15-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9-[[(2,2,2-trichloroethoxy)carbonyl]oxy]-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
|
C34H39Cl3O13 |
详情 |
详情
|
(IX) |
55695 |
5-((1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-2-(benzoyloxy)-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-{[(2,2,2-trichloroethoxy)carbonyl]oxy}-6-oxatetracyclo[11.3.1.0~3,10~.0~4,7~]heptadec-13-en-15-yl) 3-(2-propynyl) (4S,5R)-2,2-dimethyl-4-phenyl-1,3-oxazolidine-3,5-dicarboxylate |
|
C50H54Cl3NO17 |
详情 |
详情
|
(X) |
10554 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-[[(2R,3S)-3-amino-2-hydroxy-3-phenylpropanoyl]oxy]-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-9-[[(2,2,2-trichloroethoxy)carbonyl]oxy]-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate |
|
C43H48Cl3NO15 |
详情 |
详情
|
(XI) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(XII) |
55696 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-12-(acetyloxy)-15-{[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoyl]oxy}-1,4-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9-{[(2,2,2-trichloroethoxy)carbonyl]oxy}-6-oxatetracyclo[11.3.1.0~3,10~.0~4,7~]heptadec-13-en-2-yl benzoate |
|
C48H50Cl3NO15 |
详情 |
详情
|
合成路线20
该中间体在本合成路线中的序号:
(III) The hydrogenation of the protected taxol derivative (I) with H2 over Pd/C in aqueous THF in the presence of HCl gives the 3'-amino-taxol derivative (II), which is N-benzoylated by means of benzoyl chloride (III) and TEA to provide the target paclitaxel.
【1】
McChesney, J.D.; Zygmunt, J. (NaPro BioTherapeutics, Inc.); Two-step conversion of protected taxane ester to paclitaxel. WO 0285878 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
56876 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-15-({(2R,3S)-3-{[(benzyloxy)carbonyl]amino}-2-[(benzyloxy)methoxy]-3-phenylpropanoyl}oxy)-9-{[(benzyloxy)carbonyl]oxy}-1-hydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0~3,10~.0~4,7~]heptadec-13-en-2-yl benzoate |
|
C64H67NO18 |
详情 |
详情
|
(II) |
10729 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-[[(2R,3S)-3-amino-2-hydroxy-3-phenylpropanoyl]oxy]-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
|
C40H47NO13 |
详情 |
详情
|
(III) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
合成路线21
该中间体在本合成路线中的序号:
The benzoylation of 2'-deoxy-5-iodouridine (I) with benzoyl chloride by means of pyridine in dichloromethane gives 5'-O-benzoyl-2'-deoxy-5-iodouridine (II), which is treated with benzyl trichloroacetimidate (III) and trifluoromethanesulfonic acid in dichloromethane - THF to afford the 3'-O-benzyl derivative (IV). The hydrolysis of (IV) with sodium ethoxide in ethanol yields 3'-O-benzyl-2'-deoxy-5-iodouridine (V), which is finally trifluoromethylated with bromotrifluoromethane and copper in pyridine-DMF by means of dimethylaminopyridine.
The tritylation of 2'-deoxyuridine (IX) with trityl chloride in hot pyridine gives 2'-deoxy-5'-O-trityluridine (X), which is benzylated with benzyl chloride and NaH in THF yielding 3'-O-benzyl-2'-deoxy-5'-O-trityluridine (XI). The photochemical trifluoromethylation of (XI) with N-nitroso-N-(trifluoromethyl)trifluoromethanesulfonamide and biacetyl in acetonitrile irradiated with a high-pressure Hg lamp in a glass tube at room temperature affords 3'-O-benzyl-2'-deoxy-5-(trifluoromethyl-5'-O-trityluridine (XII), which is finally deprotected with HCl in methanol.
【1】
Fujii, S.; Yamashita, J.; Matsumoto, H.; Takeda, S.; Terada, T.; Yasumoto, M.; Unemi, N. (Taiho Pharmaceutical Co., Ltd.); Novel 2'-deoxy-5-substd. uridine derivs., processes for preparing the same and antitumor agent containing the same. EP 0129984; ES 8606381; ES 8606382; ES 8607982; ES 8706715; JP 1984216899; JP 1985061591 . |
【2】
Yasumoto, M.; Matsumoto, H.; Tada, Y.; Kobayashi, K.; Noguchi, K. (Taiho Pharmaceutical Co., Ltd.); Method for the preparation of 3'-O-benzyl-2'-deoxy-beta-uridines. JP 1987187484 .
|
【3】
Yamashita, J.-I.; Takeda, S.; Matsumoto, H.; Unemi, N.; Yasumoto, M.; Studies on antitumor agents. 8. Antitumor activities of O-alkyl derivatives of 2'-deoxy-5-(trifluoromethyl)uridine and 2'-deoxy-5-fluorouridine. J Med Chem 1989, 32, 1, 136-139.
|
【4】
Hoshi, A.; Prous, J.; Castaner, J.; FTC-092. Drugs Fut 1990, 15, 8, 790.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
|
19171 |
1-(Chloromethyl)benzene; Benzyl chloride
|
100-44-7 |
C7H7Cl |
详情 | 详情
|
(I) |
31154 |
1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-5-iodo-2,4(1H,3H)-pyrimidinedione
|
54-42-2 |
C9H11IN2O5 |
详情 | 详情
|
(II) |
31155 |
[(2R,3S,5R)-3-hydroxy-5-[5-iodo-2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl]tetrahydro-2-furanyl]methyl benzoate
|
|
C16H15IN2O6 |
详情 |
详情
|
(III) |
31156 |
benzyl 2,2,2-trichloroethanimidoate
|
81927-55-1 |
C9H8Cl3NO |
详情 | 详情
|
(IV) |
31157 |
[(2R,3S,5R)-3-(benzyloxy)-5-[5-iodo-2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl]tetrahydro-2-furanyl]methyl benzoate
|
|
C23H21IN2O6 |
详情 |
详情
|
(V) |
31158 |
1-[(2R,4S,5R)-4-(benzyloxy)-5-(hydroxymethyl)tetrahydro-2-furanyl]-5-iodo-2,4(1H,3H)-pyrimidinedione
|
|
C16H17IN2O5 |
详情 |
详情
|
(IX) |
11875 |
1-[(2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2,4(1H,3H)-pyrimidinedione; 2'-Deoxyuridine
|
951-78-0 |
C9H12N2O5 |
详情 | 详情
|
(X) |
31159 |
1-[(2R,4S,5R)-4-hydroxy-5-[(trityloxy)methyl]tetrahydro-2-furanyl]-2,4(1H,3H)-pyrimidinedione
|
|
C28H26N2O5 |
详情 |
详情
|
(XI) |
31160 |
1-[(2R,4S,5R)-4-(benzyloxy)-5-[(trityloxy)methyl]tetrahydro-2-furanyl]-2,4(1H,3H)-pyrimidinedione
|
|
C35H32N2O5 |
详情 |
详情
|
(XII) |
31161 |
1-[(2R,4S,5R)-4-(benzyloxy)-5-[(trityloxy)methyl]tetrahydro-2-furanyl]-5-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione
|
|
C36H31F3N2O5 |
详情 |
详情
|
合成路线22
该中间体在本合成路线中的序号:
The benzoylation of 2'-deoxy-5-(trifluoromethyl)uridine (VI) with benzoyl chloride by means of triethylamine in dimethylacetamide gives 3-benzoyl-2'-deoxy-5-(trifluoromethyl)uridine (VII), which is benzylated with benzyl bromide and silver oxide in refluxing 2-butanone to afford 3-benzoyl-3'-O-benzyl-2'-deoxy-5-(trifluoromethyl)uridine (VIII). Finally, this compound is debenzoylated with 30% aqueous ammonia at room temperature.
The deprotection of 2'-deoxy-3'-O-(thiobenzoyl)-5-(trifluoromethyl)-5'-O-trityluridine (XIII) with 0.1N HCl gives 2'-deoxy-3'-O-(thiobenzoyl)-5-(trifluoromethyl)uridine (XIV), which is submitted to desulfurization with Raney-Ni in THF.
【1】
Noguchi, K.; Yasumoto, M.; Kobayashi, K. (Taiho Pharmaceutical Co., Ltd.); Method for the preparation of 5-trifluromethyl-2'-deoxy-beta-uridines. JP 1988145296 .
|
【2】
Yamashita, J.-I.; Matsumoto, H.; Kobayashi, K.; Noguchi, K.; Yasumoto, M.; Ueda, T.; Studies on antitumor agents. IX. Synthesis of 3'-O-benzyl-2'-deoxy-5-trifluromethyluridine. Chem Pharm Bull 1989, 37, 9, 2287-92.
|
【3】
Hoshi, A.; Prous, J.; Castaner, J.; FTC-092. Drugs Fut 1990, 15, 8, 790.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
|
12912 |
1-(Bromomethyl)benzene; Alpha-bromotoluene
|
100-39-0 |
C7H7Br |
详情 | 详情
|
(VI) |
31162 |
1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-5-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione
|
70-00-8 |
C10H11F3N2O5 |
详情 | 详情
|
(VII) |
31163 |
3-benzoyl-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-5-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione
|
|
C17H15F3N2O6 |
详情 |
详情
|
(VIII) |
31164 |
3-benzoyl-1-[(2R,4S,5R)-4-(benzyloxy)-5-(hydroxymethyl)tetrahydro-2-furanyl]-5-(trifluoromethyl)-2,4(1H,3H)-pyrimidinedione
|
|
C24H21F3N2O6 |
详情 |
详情
|
(XIII) |
31165 |
O-[(2R,3S,5R)-5-[2,4-dioxo-5-(trifluoromethyl)-3,4-dihydro-1(2H)-pyrimidinyl]-2-[(trityloxy)methyl]tetrahydro-3-furanyl] benzenecarbothioate
|
|
C36H29F3N2O5S |
详情 |
详情
|
(XIV) |
31166 |
O-[(2R,3S,5R)-5-[2,4-dioxo-5-(trifluoromethyl)-3,4-dihydro-1(2H)-pyrimidinyl]-2-(hydroxymethyl)tetrahydro-3-furanyl] benzenecarbothioate
|
|
C17H15F3N2O5S |
详情 |
详情
|
合成路线23
该中间体在本合成路线中的序号:
The condensation of 1-benzoyl-1,2,2a,3,4,5-hexahydrobenzo[c,d]indol-4-one (I) with methylamine followed by acylation of the resulting enamine with benzoyl chloride gives 1,N-dibenzoyl-4-(methylamino)-1,2,2a,3-tetrahydrobenzo[c,d]indole (II) which, by irradiation with UV light in acetone, is isomerized to (5aR*,6aS*,12bS*)-4-benzoyl-7-methyl-4,5,5a,6,6a,7,8,12b-octahydroindolo[4,3-ab]phenanthridin-8-one (III). The reduction of (III) with LiAlH4 in ether, followed by hydrolysis with NaOH, and optical resolution with (+)-mandelic acid affords (+)-(5aS,6aR,12bR)-7-methyl-4,5,5a,6,6a,7,8,12b-octahydroindolo[4,3-ab]phenanthridine (IV), which is finally dehydrogenated with MnO2 in methylene chloride.
【1】
Hagenbach, A.; Seiler, M.P.; Wuthrich, H.J. (Novartis AG; Novartis Deutschland GmbH); Indolophenanthidines, their preparation and use. DE 3402392; EP 0155903; ES 8606339; JP 1985197687; US 4634708 .
|
【2】
Prous, J.; Castaner, J.; CY-208-243. Drugs Fut 1990, 15, 4, 344.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(I) |
11143 |
1-Benzoyl-1,2,2a,5-tetrahydrobenzo[cd]indol-4(3H)-one
|
|
C18H15NO2 |
详情 |
详情
|
(II) |
11144 |
N-(1-Benzoyl-1,2,2a,3-tetrahydrobenzo[cd]indol-4-yl)-N-methylbenzamide
|
|
C26H22N2O2 |
详情 |
详情
|
(III) |
11145 |
(5aR,6aR,12bS)-4-Benzoyl-7-methyl-4,5,5a,6a,7,12b-hexahydroindolo[4,3-ab]phenanthridin-8(6H)-one
|
|
C26H22N2O2 |
详情 |
详情
|
(IV) |
11146 |
(5aR,6aR,12bR)-7-Methyl-4,5,5a,6,6a,7,8,12b-octahydroindolo[4,3-ab]phenanthridine
|
|
C19H20N2 |
详情 |
详情
|
合成路线24
该中间体在本合成路线中的序号:
(C) The dehydrogenation of 3beta-hydroxycholest-5-en-24-one with dichlorodicyanobenzoquinone in refluxing dioxane, or of cholest-4-ene-3,24-dione (II) with chloranil in refluxing tert-butyl alcohol gives cholesta-1,4,6-triene-3,24-dione (III), which is epoxidized with 30% H2O2 and NaOH in methanol-dioxane-THF yielding 1 alpha,2alpha-epoxycholesta-4,6-diene-3,24-dione (IV). The reduction of (IV) with Li in liquid NH3 affords 1alpha,3beta,24-trihydroxycholest-5-ene (V), which is benzoylated with benzoyl chloride in pyridine and submitted to column chromatography on silica gel to give 1alpha,3beta,24R-tribenzoyloxycholest-5-ene (VI). The dehydrogenation of (VI) with dibromodimethylhydantoin of N-bromosuccinimide yields lalpha,3beta,24R-trihydroxy-cholesta-5,7-diene (VII), which is finally submitted to irradiation with a medium-pressure Hg lamp in ether.
【1】
Ikekawa, N.; Koizumi, N.; Morisaki, M.; Synthesis of active forms of vitamin D. Part IX. S. J Chem Soc - Perkins Trans I 1975, 1421.
|
【2】
Takeshita, T.; Hashimoto, Y.; Kawashima, H.; Ishimoto, S.; Ikekawa, N.; Morisaki, M. (Teijin Ltd.); 1alpha,24-Dihydroxycholecalciferol derivs. and pro. DE 2526981; US 4022891 .
|
【3】
Castaner, J.; Prous, J.; TV-02. Drugs Fut 1988, 13, 2, 133.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
21890 |
2,3-dichloro-5,6-dicyano-1,4-benzoquinone; 4,5-dichloro-3,6-dioxo-1,4-cyclohexadiene-1,2-dicarbonitrile
|
84-58-2 |
C8Cl2N2O2 |
详情 | 详情
|
(B) |
21891 |
2,3,5,6-Tetrachloro-1,4-benzoquinone; 2,3,5,6-Tetrachlorobenzo-1,4-quinone; p-Chloranil
|
118-75-2 |
C6Cl4O2 |
详情 | 详情
|
(I) |
21883 |
6-[(3S,10R,13R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-3-heptanone
|
|
C27H44O2 |
详情 |
详情
|
(II) |
21884 |
(10R,13R)-17-(1,5-dimethyl-4-oxohexyl)-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one
|
|
C27H42O2 |
详情 |
详情
|
(III) |
21885 |
(10S,13R)-17-(1,5-dimethyl-4-oxohexyl)-10,13-dimethyl-8,9,10,11,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-3-one
|
|
C27H38O2 |
详情 |
详情
|
(IV) |
21886 |
(2aR,3aR,3bR,5aR)-6-(1,5-dimethyl-4-oxohexyl)-3b,5a-dimethyl-2a,3a,3b,3c,4,5,5a,6,7,8,8a,8b-dodecahydro-2H-cyclopenta[7,8]phenanthro[3,4-b]oxiren-2-one
|
|
C27H38O3 |
详情 |
详情
|
(V) |
21887 |
(1S,3R,10R,13R)-17-(4-hydroxy-1,5-dimethylhexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-1,3-diol
|
|
C27H46O3 |
详情 |
详情
|
(VI) |
21888 |
(1S,3R,10R,13R)-1-(benzoyloxy)-17-[(4R)-4-(benzoyloxy)-1,5-dimethylhexyl]-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl benzoate
|
|
C48H58O6 |
详情 |
详情
|
(VII) |
21889 |
(1S,3R,10R,13R)-17-[(4R)-4-hydroxy-1,5-dimethylhexyl]-10,13-dimethyl-2,3,4,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-1,3-diol
|
|
C27H44O3 |
详情 |
详情
|
(C) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
合成路线25
该中间体在本合成路线中的序号:
(A) The cyclization of 2,4-dichlorophenacyl bromide (I) with glycerol (II) gives cis-2-(2,4-dichlorophenyl)-2-bromomethyl-4-hydroxymethyl-1,3-dioxolane (III), which is then benzoylated with benzoyl chloride (A) yielding cis-2-(2,4-dichlorophenyl)-2-bromomethyl-4-benzoyloxymethyl-1,3-dioxolane (IV). The condensation of (IV) with 1H-imidazole (V) affords cis-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-4-benzoyloxymethyl-1,3-dioxolane (VI), which is then debenzoylated in basic medium giving cis-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-4-hydroxymethyl-1,3-dioxolane (VII). The reaction of (VII) with methanesulfonyl chloride (B) yields cis-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-ylmethyl methanesulfonate (VIII). Finally, this compound is condensed with 1-acetyl-4-(4-hydroxyphenyl)piperazine (IX) by means of NaH in benzene - DMSO. Compound (IX) is obtained by reaction of 4-(1-piperazinyl)phenol dihydrobromide (X) with acetic anhydride by means of K2CO3 in refluxing acetic acid.
【1】
Heeres, J.; et al.; DE 2804096 .
|
【2】
Blancafort, P.; Sweetman, A.J.; Castaner, J.; Serradell, M.N.; Ketoconazole. Drugs Fut 1979, 4, 7, 496.
|
【3】
Backx, L.J.J.; Mostmans, J.H.; Heeres, J. (Janssen Pharmaceutica NV); 1-(1,3-Dioxolan-2-ylmethyl)-1H-imidazoles. US 4335125 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(B) |
13467 |
Methanesulfonyl chloride;Mesyl chloride;Methylsulfonyl chloride;Methanesulfonic acid chloride;Methanesulfonyl chloride;Methanesulphonyl chloride |
124-63-0 |
CH3ClO2S |
详情 | 详情
|
(I) |
36408 |
2-bromo-1-(2,4-dichlorophenyl)-1-ethanone
|
|
C8H5BrCl2O |
详情 |
详情
|
(II) |
13289 |
Glycerine; Glycerin; Glycerol
|
56-81-5 |
C3H8O3 |
详情 | 详情
|
(III) |
39602 |
[(2S,4R)-2-(bromomethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl]methanol
|
|
C11H11BrCl2O3 |
详情 |
详情
|
(IV) |
30485 |
[(2S,4S)-2-(bromomethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl]methyl benzoate; cis-2-(bromomethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl]methyl benzoate
|
|
C18H15BrCl2O4 |
详情 |
详情
|
(V) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(VI) |
39603 |
[(2S,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl benzoate
|
|
C21H18Cl2N2O4 |
详情 |
详情
|
(VII) |
39604 |
[(2S,4R)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methanol
|
170210-50-1 |
C14H14Cl2N2O3 |
详情 | 详情
|
(VIII) |
39605 |
[(2S,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl methanesulfonate; cis-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl methanesulfonate
|
|
C15H16Cl2N2O5S |
详情 |
详情
|
(IX) |
29119 |
1-Acetyl-4-(4-hydoxyphenyl)piperazine; 1-[4-(4-hydroxyphenyl)-1-piperazinyl]-1-ethanone; N-Acetyl-4-(4-hydoxyphenyl)piperazine
|
67914-60-7 |
C12H16N2O2 |
详情 | 详情
|
(X) |
39606 |
4-(1-piperazinyl)phenol; 1-(4-Hydroxyphenyl)piperazine
|
56621-48-8 |
C10H14N2O |
详情 | 详情
|
合成路线26
该中间体在本合成路线中的序号:
(II) The reaction of lovastatin (I) with benzoyl chloride (II) and pyridine gives the expected benzoate (III), which is treated with ethyleneglycol (IV), triethyl orthoformate and H2SO4 to yield the cyclic orthoformate (V). The methylation of (V) by means of MeI and BuLi in pyrrolidine affords the 2,2-dimethylbutyrate ester (VI), which is finally deprotected with HCl in THF to provide the target simvastatin.
【1】
Dabak, K.; Adiyaman, M.; A new method for the synthesis of antihypercholesterolemic agent simvastatin. Helv Chim Acta 2003, 86, 3, 673.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
64415 |
(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-1-naphthalenyl (2S)-2-methylbutanoate
|
|
C24H36O5 |
详情 |
详情
|
(II) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(III) |
64416 |
(2R,4R)-2-[2-((1S,2S,6R,8S,8aR)-2,6-dimethyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydro-1-naphthalenyl)ethyl]-6-oxotetrahydro-2H-pyran-4-yl benzoate
|
|
C31H40O6 |
详情 |
详情
|
(IV) |
11295 |
Polyethylene glycol;1,2-Ethanediol;Monoethylene glycol; Ethylene glycol |
107-21-1 |
C2H6O2 |
详情 | 详情
|
(V) |
64417 |
(7R,9R)-7-[2-((1S,2S,6R,8S,8aR)-2,6-dimethyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydro-1-naphthalenyl)ethyl]-1,4,6-trioxaspiro[4.5]dec-9-yl benzoate
|
|
C33H44O7 |
详情 |
详情
|
(VI) |
64418 |
(1S,3R,7S,8S,8aR)-8-{2-[(7R,9R)-9-hydroxy-1,4,6-trioxaspiro[4.5]dec-7-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-1-naphthalenyl 2,2-dimethylbutanoate
|
|
C27H42O6 |
详情 |
详情
|
合成路线27
该中间体在本合成路线中的序号:
(II) The benzoylation of thiazolidine-4(R)-carboxylic acid (I) with benzoyl chloride (II) by means of NaOH in acetone water gives the corresponding N-benzoyl derivative (III), which is then condensed with alpha-(R)-methylbenzylamine (IV) by means of isobutyl chloroformate and triethylamine in dichloromethane.
【1】
Matsui, T.; Nagano, M.; KLitamura, K.; Shimizu, F. (Sankyo Co., Ltd.); Amino acid derivatives having anti-tumor activity and compositions containing them.. EP 0173441; ES 8703830; US 4904680 .
|
【2】
Castaner, J.; Prous, J.; RS-0481. Drugs Fut 1988, 13, 7, 627.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
13423 |
1-[(Chlorocarbonyl)oxy]-2-methylpropane; Isobutyl chloroformate;isobutyl carbonochloridate |
543-27-1 |
C5H9ClO2 |
详情 | 详情
|
(I) |
12899 |
L-(-)-Thiazolidine-4-carboxylic acid; (4R)-1,3-Thiazolidine-4-carboxylic acid; (R)-(-)-Thiazolidine-4-carboxylic acid
|
34592-47-7 |
C4H7NO2S |
详情 | 详情
|
(II) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(III) |
22557 |
(4R)-3-benzoyl-1,3-thiazolidine-4-carboxylic acid
|
|
C11H11NO3S |
详情 |
详情
|
(IV) |
10039 |
(1R)-1-Phenylethylamine; (1R)-1-Phenyl-1-ethanamine.; L-alpha-Phenylethylamine
|
3886-69-9 |
C8H11N |
详情 | 详情
|
合成路线28
该中间体在本合成路线中的序号:
(VI) 4-Chloro-alpha-methylbenzhydrol (I) is alkylated with N-(2-chloroethyl)hexamethyleneimine (II) in benzene in the presence of sodium amide to give setastine. The starting products are obtained as follows; Caprolactame (III) is O-alkylated with dimethyl sulfate to yield the lactimether (IV), which is reduced with sodium borohydride to hexamethyleneimine (II). Friedel Cratts acylation of chlorobenzene (V) with benzoyl chloride (VI) affords the benzophenone (VII), to which methylmagnesium bromide is added to give the carbinol (I).
【1】
Rakoczi, J.; Bolla, K.; Beck, I.; Porszasz, K. (Egis Pharmaceuticals Ltd.); New benzhydryloxy-alkylamine derivs. and process f. DE 2528194; GB 1463038 .
|
【2】
Nogradi, M.; Setastine hydrochloride. Drugs Fut 1987, 12, 4, 357.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22917 |
1-(4-chlorophenyl)-1-phenyl-1-ethanol
|
|
C14H13ClO |
详情 |
详情
|
(II) |
22918 |
1-(2-chloroethyl)azepane
|
|
C8H16ClN |
详情 |
详情
|
(III) |
22919 |
2-azepanone
|
105-60-2 |
C6H11NO |
详情 | 详情
|
(IV) |
22920 |
7-methoxy-3,4,5,6-tetrahydro-2H-azepine; methyl 3,4,5,6-tetrahydro-2H-azepin-7-yl ether
|
2525-16-8 |
C7H13NO |
详情 | 详情
|
(V) |
10190 |
1-Chlorobenzene
|
108-90-7 |
C6H5Cl |
详情 | 详情
|
(VI) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(VII) |
22923 |
(4-chlorophenyl)(phenyl)methanone; 4-Chlorobenzophenone
|
134-85-0 |
C13H9ClO |
详情 | 详情
|
合成路线29
该中间体在本合成路线中的序号:
(II) 1) The Friedel-Crafts condensation of 4,7-dichloro-2,3-dihydrobenzofuran-2-carboxylic acid ethyl ester (I) with benzoyl chloride (II) by means of AlCl3 in dichloroethane, followed by hydrolysis with ethanolic NaOH gives 5-benzoyl-4,7-dichloro-2,3-dihydrobenzofuran-2-carboxylic acid (III), which by reaction with hydroxylamine in refluxing pyridine is converted into the corresponding oxime (IV). Finally, this compound is cyclized with NaH in DMF or with KOH in ethanol.
2) The Friedel-Crafts condensation of (V) with (II) as before gives 2-hydroxy-4-methoxybenzophenone (XVI), which by cyclocondensation with hydroxylamine as before is converted into 6-methoxy-3-phenyl-1,2-benzisoxazole (XVII). Demethylation of (XVII) as already indicated yields 6-hydroxy-3-phenyl-1,2-benzisoxazole (XVIII), which is converted into the allyloxy derivative (XIX). The rearrangement of (XIX) with N,N-dimethylamine as before affords the 7-allyl derivative (XX), which is cyclized with m-chloroperbenzoic acid (m-CPBA) to 3-phenyl-7,8-dihydrofuro[2,3-g]-1,2-benzisoxazole-7-methanol (XXI). Finally, this compound is chlorinated with SO2Cl2 in CH2Cl2 yielding compound (XV), which is oxidized with CrO3 / H2SO4 or KMnO4 in dichloromethane.
【1】
Sato, H.; Koga, H.; Dan, T.; Onuma, E. (Chugai Pharmaceutical Co. Ltd.); Furobenzisoxazole derivs. EP 0205872; US 4791209 .
|
【2】
Koga, H.; Sato, H. (Chugai Pharmaceutical Co. Ltd.); Method for the preparation of furobenzisoxazole derivs. JP 1989131180 .
|
【3】
Koga, H.; Sato, H. (Chugai Pharmaceutical Co. Ltd.); Method for the synthesis of furobenzisoxazole derivs. JP 1989143876 .
|
【4】
Koga, H.; Sato, H. (Chugai Pharmaceutical Co. Ltd.); Industrial process for the preparation of furobenzisoxazole derivs. JP 1989143875 .
|
【5】
Prous, J.; Castaner, J.; AA-193. Drugs Fut 1991, 16, 11, 985.
|
【6】
Onuma, E.; Dan, T.; Koga, H.; Sato, H.; Aoki, B.; Tanaka, H.; Studies on uricosuric diuretics. II. Substituted 7,8-dihydrofuro[2,3-g]-1,2-benzisoxazole-7-carboxylic acids and 7,8-dihydrofuro[2,3-g]benzoxazole-7-carboxylic acids. Chem Pharm Bull 1991, 39, 7, 1760-72. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11930 |
ethyl 4,7-dichloro-2,3-dihydro-1-benzofuran-2-carboxylate
|
|
C11H10Cl2O3 |
详情 |
详情
|
(II) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(III) |
11932 |
5-Benzoyl-4,7-dichloro-2,3-dihydro-1-benzofuran-2-carboxylic acid
|
|
C16H10Cl2O4 |
详情 |
详情
|
(IV) |
11933 |
4,7-Dichloro-5-[(hydroxyimino)(phenyl)methyl]-2,3-dihydro-1-benzofuran-2-carboxylic acid
|
|
C16H11Cl2NO4 |
详情 |
详情
|
(V) |
11934 |
m-Dimethoxybenzene; 1,3-Dimethoxybenzene; 3-Methoxyphenyl methyl ether
|
151-10-0 |
C8H10O2 |
详情 | 详情
|
(XV) |
11941 |
(5-Chloro-3-phenyl-7,8-dihydrofuro[2,3-g][1,2]benzisoxazol-7-yl)methanol
|
|
C16H12ClNO3 |
详情 |
详情
|
(XVI) |
11935 |
2-Hydroxy-4-methoxybenzophenone; (2-Hydroxy-4-methoxyphenyl)(phenyl)methanone
|
131-57-7 |
C14H12O3 |
详情 | 详情
|
(XVII) |
11936 |
Methyl 3-phenyl-1,2-benzisoxazol-6-yl ether; 6-Methoxy-3-phenyl-1,2-benzisoxazole
|
|
C14H11NO2 |
详情 |
详情
|
(XVIII) |
11937 |
3-Phenyl-1,2-benzisoxazol-6-ol
|
|
C13H9NO2 |
详情 |
详情
|
(XIX) |
11938 |
6-(Allyloxy)-3-phenyl-1,2-benzisoxazole; Allyl 3-phenyl-1,2-benzisoxazol-6-yl ether
|
|
C16H13NO2 |
详情 |
详情
|
(XX) |
11939 |
7-Allyl-3-phenyl-1,2-benzisoxazol-6-ol
|
|
C16H13NO2 |
详情 |
详情
|
(XXI) |
11940 |
(3-Phenyl-7,8-dihydrofuro[2,3-g][1,2]benzisoxazol-7-yl)methanol
|
|
C16H13NO3 |
详情 |
详情
|
合成路线30
该中间体在本合成路线中的序号:
(II) 3) The chlorination of 1,3-dimethoxybenzene (V) with SO2Cl2 in CHCl3 gives 1-chloro-2,4-dimethoxybenzene (VI), which is condensed with (II) by means of AlCl3 in dichloroethane yielding 5-chloro-2-hydroxy-4-methoxybenzophenone (VII). The cyclocondensation of (VII) with hydroxylamine - HCl and then with acetic anhydride - sodium acetate in refluxing DMF affords 5-chloro-6-methoxy-3-phenyl-1,2-benzoisoxazole (VIII), which is demethylated with pyridine hydrochloride at 180 C, giving 5-chloro-6-hydroxy-3-phenyl-1,2-benzoisoxazole (IX). The condensation of (IX) with dimethylamine and formaldehyde in water gives 5-chloro-7-(dimethylaminomethyl)-6-hydroxy-3-phenyl-1,2-benzoisoxazole (X), which is cyclized with (ethoxycarbonylmethyl)dimethylsulfonium bromide (XI) by means of K2CO3 in DMF, yielding 5-chloro-3-phenyl-7,8-dihydrofuro[2,3-g]-1,2-benzoisoxazole-7-carboxyli c acid ethyl ester (XII). Finally, this compound is hydrolyzed with NaOH in refluxing ethanol.
4) The condensation of isoxazole (IX) with allyl bromide by means of K2CO3 in DMF gives 6-allyloxy-5-chloro-3-phenyl-1,2-benzoisoxazole (XIII), which is rearranged with refluxing N,N-dimethylaniline yielding 7-allyl-5-chloro-6-hydroxy-3-phenyl-1,2-benzisoxazole (XIV). The cyclization of (XIV) with m-chloroperbenzoic acid (MCPBA) in refluxing CHCl3 or N-bromosuccinimide in DMSO affords 5-chloro-3-phenyl-7,8-dihydrofuro[2,3-g]-1,2-benzisoxazole-7-methanol (XV), which is finally oxidized with CrO3-H2SO4 in acetone or KMnO4 in dichloroethane.
5) The alkylation of phenol (IX) with ortho-acrylic acid trietyl ester (XXI) by means of pivalic acid in refluxing toluene gives the substituted chromane (XXIII), which is then treated with Br2 in pyridine-CHCl3 to afford ethyl ester (XII), already obtained.
【1】
Sato, H.; Koga, H.; Dan, T.; Onuma, E. (Chugai Pharmaceutical Co. Ltd.); Furobenzisoxazole derivs. EP 0205872; US 4791209 .
|
【2】
Koga, H.; Sato, H. (Chugai Pharmaceutical Co. Ltd.); Industrial process for the preparation of furobenzisoxazole derivs. JP 1989143875 .
|
【3】
Koga, H.; Sato, H. (Chugai Pharmaceutical Co. Ltd.); Method for the synthesis of furobenzisoxazole derivs. JP 1989143876 .
|
【4】
Koga, H.; Sato, H. (Chugai Pharmaceutical Co. Ltd.); Method for the preparation of furobenzisoxazole derivs. JP 1989131180 .
|
【5】
Prous, J.; Castaner, J.; AA-193. Drugs Fut 1991, 16, 11, 985.
|
【6】
Onuma, E.; Dan, T.; Koga, H.; Sato, H.; Aoki, B.; Tanaka, H.; Studies on uricosuric diuretics. II. Substituted 7,8-dihydrofuro[2,3-g]-1,2-benzisoxazole-7-carboxylic acids and 7,8-dihydrofuro[2,3-g]benzoxazole-7-carboxylic acids. Chem Pharm Bull 1991, 39, 7, 1760-72. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(II) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(V) |
11934 |
m-Dimethoxybenzene; 1,3-Dimethoxybenzene; 3-Methoxyphenyl methyl ether
|
151-10-0 |
C8H10O2 |
详情 | 详情
|
(VI) |
11942 |
1-Chloro-2,4-dimethoxybenzene; 2-Chloro-5-methoxyphenyl methyl ether
|
7051-13-0 |
C8H9ClO2 |
详情 | 详情
|
(VII) |
11943 |
(5-Chloro-2-hydroxy-4-methoxyphenyl)(phenyl)methanone
|
|
C14H11ClO3 |
详情 |
详情
|
(VIII) |
11944 |
5-Chloro-3-phenyl-1,2-benzisoxazol-6-yl methyl ether; 5-Chloro-6-methoxy-3-phenyl-1,2-benzisoxazole
|
|
C14H10ClNO2 |
详情 |
详情
|
(IX) |
11945 |
5-Chloro-3-phenyl-1,2-benzisoxazol-6-ol
|
|
C13H8ClNO2 |
详情 |
详情
|
(X) |
11946 |
5-Chloro-7-[(dimethylamino)methyl]-3-phenyl-1,2-benzisoxazol-6-ol
|
|
C16H15ClN2O2 |
详情 |
详情
|
(XI) |
11947 |
(2-Ethoxy-2-oxoethyl)(dimethyl)sulfonium bromide
|
5187-82-6 |
C6H13BrO2S |
详情 | 详情
|
(XII) |
11948 |
ethyl 5-chloro-3-phenyl-7,8-dihydrofuro[2,3-g][1,2]benzisoxazole-7-carboxylate
|
|
C18H14ClNO4 |
详情 |
详情
|
(XIII) |
11949 |
Allyl 5-chloro-3-phenyl-1,2-benzisoxazol-6-yl ether; 6-(Allyloxy)-5-chloro-3-phenyl-1,2-benzisoxazole
|
|
C16H12ClNO2 |
详情 |
详情
|
(XIV) |
11950 |
7-Allyl-5-chloro-3-phenyl-1,2-benzisoxazol-6-ol
|
|
C16H12ClNO2 |
详情 |
详情
|
(XV) |
11941 |
(5-Chloro-3-phenyl-7,8-dihydrofuro[2,3-g][1,2]benzisoxazol-7-yl)methanol
|
|
C16H12ClNO3 |
详情 |
详情
|
(XXII) |
11951 |
3,3,3-Triethoxy-1-propene; 1,1-Diethoxy-2-propenyl ethyl ether
|
|
C9H18O3 |
详情 |
详情
|
(XXIII) |
11952 |
5-Chloro-7-ethoxy-3-phenyl-8,9-dihydro-7H-chromeno[6,5-d]isoxazol-7-yl ethyl ether; 5-Chloro-7,7-diethoxy-3-phenyl-8,9-dihydro-7H-chromeno[6,5-d]isoxazole
|
|
C20H20ClNO4 |
详情 |
详情
|
合成路线31
该中间体在本合成路线中的序号:
(II) Several related syntheses for AA-193 have been reported:
1) The Friedel-Crafts' condensation of 2,5-dichlorophenol (I) with benzoyl chloride (II) by means of AlCl3 gives 2,5-dichloro-4-hydroxybenzophenone (III), which by reaction with hydroxylamine and KOH is converted to 5-chloro-6-hydroxy-3-phenylbenzisoxazole (IV). The condensation of (IV) with allyl bromide (V) by means of K2CO3 affords the 7-allyl derivative (VI), which is cyclized by means of N-bromosuccinimide and NaOH to 5-chloro-7-(hydroxymethyl)-3-phenyl-7,8-dihydrofuro[2,3-g]-1,2-benzisox azole (VII). Finally, this compound is oxidized to the final product with KMnO4 in refluxing dichloromethane.
2) The chlorination of 1,3-dimethoxybenzene (VIII) with SO2Cl2 gives 1-chloro-2,4-dimethoxybenzene (IX), which is condensed with benzoyl chloride (II) as before, yielding 5-chloro-2,4-dihydroxybenzophenone (X). Tosylation of (X) with tosyl chloride gives the corresponding ditosyl derivative (XI), which by reaction with hydroxylamine is converted to the oxime (XII). Finally, this compound is treated with KOH in order to cyclize to the benzisoxazole (IV).
3) The reaction of the benzisoxazole (IV) with formaldehyde and dimethylamine gives 5-chloro-7-(dimethylaminomethyl)-6-hydroxy-3-phenylbenzisoxazole (XIII), which is condensed and cyclized with the ylide (XIV) to yield the ethyl ester of the desired product (XV). Finally, this compound is hydrolyzed with NaOH.
【1】
Koga, H.; Kuromaru, K.; Ishizawa, T.; Aoki, B.; Sato, H.; Studies on uricosuric diuretics. V. Convenient and efficient synthesis of 2,3-dihydrobenzofuran derivatives. Chem Pharm Bull 1992, 40, 10, 2597.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11953 |
2,5-Dichlorophenol
|
583-78-8 |
C6H4Cl2O |
详情 | 详情
|
(II) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(III) |
11955 |
(2,5-Dichloro-4-hydroxyphenyl)(phenyl)methanone
|
|
C13H8Cl2O2 |
详情 |
详情
|
(IV) |
11945 |
5-Chloro-3-phenyl-1,2-benzisoxazol-6-ol
|
|
C13H8ClNO2 |
详情 |
详情
|
(V) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(VI) |
11950 |
7-Allyl-5-chloro-3-phenyl-1,2-benzisoxazol-6-ol
|
|
C16H12ClNO2 |
详情 |
详情
|
(VII) |
11941 |
(5-Chloro-3-phenyl-7,8-dihydrofuro[2,3-g][1,2]benzisoxazol-7-yl)methanol
|
|
C16H12ClNO3 |
详情 |
详情
|
(VIII) |
11934 |
m-Dimethoxybenzene; 1,3-Dimethoxybenzene; 3-Methoxyphenyl methyl ether
|
151-10-0 |
C8H10O2 |
详情 | 详情
|
(IX) |
11942 |
1-Chloro-2,4-dimethoxybenzene; 2-Chloro-5-methoxyphenyl methyl ether
|
7051-13-0 |
C8H9ClO2 |
详情 | 详情
|
(X) |
11962 |
(5-Chloro-2,4-dihydroxyphenyl)(phenyl)methanone
|
|
C13H9ClO3 |
详情 |
详情
|
(XI) |
11963 |
2-benzoyl-4-chloro-5-[[(4-methylphenyl)sulfonyl]oxy]phenyl 4-methylbenzenesulfonate
|
|
C27H21ClO7S2 |
详情 |
详情
|
(XII) |
11964 |
4-chloro-2-[(hydroxyimino)(phenyl)methyl]-5-[[(4-methylphenyl)sulfonyl]oxy]phenyl 4-methylbenzenesulfonate
|
|
C27H22ClNO7S2 |
详情 |
详情
|
(XIII) |
11946 |
5-Chloro-7-[(dimethylamino)methyl]-3-phenyl-1,2-benzisoxazol-6-ol
|
|
C16H15ClN2O2 |
详情 |
详情
|
(XIV) |
11966 |
2-(Dimethylsulfonium)acetic acid ethyl ester inner salt
|
|
C6H12O2S |
详情 |
详情
|
(XV) |
11948 |
ethyl 5-chloro-3-phenyl-7,8-dihydrofuro[2,3-g][1,2]benzisoxazole-7-carboxylate
|
|
C18H14ClNO4 |
详情 |
详情
|
合成路线32
该中间体在本合成路线中的序号:
(VI) By condensation of 3-[3-(chlorocarbonyl)benzoyl]-1-(ethoxymethyl)-5-fluorouracil (I) with 6-benzoyloxy-3-cyano-2-hydroxypyridine (II) by means of triethylamine in refluxing acetonitrile.
The starting compounds (I) and (II) are obtained as follows:
The reaction of 1-(ethoxymethyl)-5-fluorouracil (III) with isophthaloyl dichloride (IV) by means of triethylamine in refluxing dioxane gives uracil (I).
The esterification of 3-cyano-2,6-dihydroxypyridine (V) with benzoyl chloride (VI) by means of triethylamine in dimethylacetamide affords pyridine (II).
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12498 |
3-[[3-(Ethoxymethyl)-5-fluoro-2,6-dioxo-3,6-dihydro-1(2H)-pyrimidinyl]carbonyl]benzoyl chloride
|
|
C15H12ClFN2O5 |
详情 |
详情
|
(II) |
12499 |
5-cyano-6-hydroxy-2-pyridinyl benzoate
|
|
C13H8N2O3 |
详情 |
详情
|
(III) |
12500 |
1-(Ethoxymethyl)-5-fluoro-2,4(1H,3H)-pyrimidinedione
|
|
C7H9FN2O3 |
详情 |
详情
|
(IV) |
12501 |
Isophthaloyl dichloride
|
99-63-8 |
C8H4Cl2O2 |
详情 | 详情
|
(V) |
12502 |
2,6-Dihydroxynicotinonitrile
|
|
C6H4N2O2 |
详情 |
详情
|
(VI) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
合成路线33
该中间体在本合成路线中的序号:
(II) The reaction of [benzene-U-13C]benzoic acid (I) with SOCl2 gives the corresponding acyl chloride (II), which is cyclized with the ethanolamine (III) to yield the oxazoline (IV).The chlorination of (IV) with sec-BuLi and hexachloroethane in toluene affords the 2-chlorophenyl derivative (V), which is methylated with MeI to provide the oxazolinium salt (VI). The reduction of (VI) with NaBH4 in ethanol yields the oxazolidine (VII), which is hydrolyzed with HCl to afford the labeled 2-chlorobenzaldehyde (VIII). The condensation of aldehyde (VIII) with the tetrahydrothienopyridine (IX) by means of acetone cyanohydrine in hot toluene affords the substituted acetonitrile (X), which is hydrolyzed to the substituted acetamide (XI) with HCl in methanol. Finally, this compound is treated with H2SO4 in refluxing methanol to afford the target labeled methyl ester as a racemic mixture.
【1】
Kashimura, S.; Kuwata, F.; Ishige, O.; Uyama, H.; Shono, T.; Yamaguchi, Y.; Formation of a novel acyl anion equivalent by the electroreduction of oxazolinium salts. Chem Lett 1987, 1511.
|
【2】
Burgos, A.; Simpson, I.; Herbert, J.M.; Ortho-metalation/chlorination of benzoic acid derivatives: Preparation of [benzene-U-C-13]-rac-clopidogrel ([benzene-U-C-13]-rac-SR25990C). J Label Compd Radiopharm 2000, 43, 9, 891.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
63476 |
methyl 2-(2-chlorophenyl)-2-[6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]acetate
|
|
C16H16ClNO2S |
详情 |
详情
|
|
63477 |
methyl 2-(2-chlorophenyl)-2-[6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]acetate
|
|
C16H16ClNO2S |
详情 |
详情
|
(I) |
10202 |
Benzoic acid
|
65-85-0 |
C7H6O2 |
详情 | 详情
|
(I) |
44623 |
|
|
C7H6O2 |
详情 |
详情
|
(II) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(II) |
45137 |
|
|
C7H5ClO |
详情 |
详情
|
(III) |
21513 |
2-amino-2-methyl-1-propanol;Karl Fischer;2-Amino-2-methyl-propan-1-ol;2-amino-2-methyl-1-propanol |
124-68-5 |
C4H11NO |
详情 | 详情
|
(IV) |
44072 |
4,4-dimethyl-2-phenyl-4,5-dihydro-1,3-oxazole
|
19312-06-2 |
C11H13NO |
详情 | 详情
|
(IV) |
45138 |
|
|
C11H13NO |
详情 |
详情
|
(V) |
44073 |
2-(2-chlorophenyl)-4,4-dimethyl-4,5-dihydro-1,3-oxazole
|
|
C11H12ClNO |
详情 |
详情
|
(V) |
45139 |
|
|
C11H12ClNO |
详情 |
详情
|
(VI) |
44074 |
2-(2-chlorophenyl)-3,4,4-trimethyl-4,5-dihydro-1,3-oxazol-3-ium iodide
|
|
C12H15ClINO |
详情 |
详情
|
(VI) |
45140 |
|
|
C12H15ClINO |
详情 |
详情
|
(VII) |
44075 |
2-(2-chlorophenyl)-3,4,4-trimethyl-1,3-oxazolidine
|
|
C12H16ClNO |
详情 |
详情
|
(VII) |
45141 |
|
|
C12H16ClNO |
详情 |
详情
|
(VIII) |
24114 |
2-chlorobenzaldehyde
|
89-98-5 |
C7H5ClO |
详情 | 详情
|
(VIII) |
45142 |
|
|
C7H5ClO |
详情 |
详情
|
(IX) |
34011 |
4,5,6,7-tetrahydrothieno[3,2-c]pyridine
|
54903-50-3 |
C7H9NS |
详情 | 详情
|
(X) |
44076 |
2-(2-chlorophenyl)-2-[6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]acetonitrile
|
|
C15H13ClN2S |
详情 |
详情
|
(X) |
45143 |
|
|
C15H13ClN2S |
详情 |
详情
|
(XI) |
44077 |
2-(2-chlorophenyl)-2-[6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]acetamide
|
|
C15H15ClN2OS |
详情 |
详情
|
(XI) |
45144 |
|
|
C15H15ClN2OS |
详情 |
详情
|
合成路线34
该中间体在本合成路线中的序号:
(VI) The protected ligand (IV) was also prepared by a related method. The acylation of thioglycolic acid (V) with benzoyl chloride (VI) under Schotten-Baumann conditions afforded S-benzoyl thioglycolic acid (VII). After activation of (VII) as the corresponding succinimidyl ester (VIII) with N-hydroxysuccinimide and DCC, coupling with triglycine (I) furnished compound (IV).
【1】
Grummon, G.; et al.; Synthesis, characterization and crystal structures of technetium(V)-oxo complexes useful in nuclear medicine. 1. Complexes of mercaptoacetylglycylglycylglycine (MAG3) and its methyl ester derivative (MAG3OMe). Inorg Chem 1995, 34, 7, 1764. |
【2】
Brandau, W.; et al.; Technetium-99m labeled renal function and imaging agents. 3. Synthesis of Tc-99m-MAG3 and biodistribution of by-products. Int J Radiat Appl Instrum Part A - Appl Radiat Isotop 1988, 39, 2, 121.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
56518 |
2-({2-[(2-aminoacetyl)amino]acetyl}amino)acetic acid
|
|
C6H11N3O4 |
详情 |
详情
|
(IV) |
56520 |
1,4,7,10-tetraoxo-1-phenyl-2-thia-5,8,11-triazatridecan-13-oic acid
|
|
C15H17N3O6S |
详情 |
详情
|
(V) |
18524 |
2-sulfanylacetic acid
|
68-11-1 |
C2H4O2S |
详情 | 详情
|
(VI) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(VII) |
56522 |
2-(benzoylsulfanyl)acetic acid
|
|
C9H8O3S |
详情 |
详情
|
(VIII) |
56523 |
S-{2-[(2,5-dioxo-1-pyrrolidinyl)oxy]-2-oxoethyl} benzenecarbothioate
|
|
C13H11NO5S |
详情 |
详情
|
合成路线35
该中间体在本合成路线中的序号:
(II) The title benzamide was prepared by acylation of the alkaloid staurosporine (I) with benzoyl chloride (II) in the presence of diisopropylethylamine in chloroform.
【1】
Caravatti, G.; et al.; Inhibitory activity and selectivity of staurosporine derivatives towards protein kinase C. Bioorg Med Chem Lett 1994, 4, 3, 399.
|
【2】
Caravatti, G.; Fredenhagen, A. (Novartis AG); Staurosporine derivs. substd. for the nitrogen atom of the methylamino group. EP 0296110; JP 1989034989; US 5093330 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
52822 |
(2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1~2,6~.0~7,28~.0~8,13~.0~15,19~.0~20,27~.0~21,26~]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-one
|
|
C28H26N4O3 |
详情 |
详情
|
(II) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
合成路线36
该中间体在本合成路线中的序号:
A new practical asymmetric synthesis of lubocavir has been described:
The diastereoselective cycloaddition of (-)-dimenthyl fumarate (I) with ketene dimethylacetal (II) by means of diisobutylaluminum chloride (DIBAC) in toluene gives the cyclobutane (III), which is reduced with LiAlH4 yielding the cyclobutyl dicarbinol (IV). The reaction of (IV) with benzoyl chloride affords the dibenzoate (V), which is deprotected in acidic medium to give the cyclobutanone (VI). The stereoselective reduction of (VI) with DIBAC yields the chiral cyclobutanol (VII), which is treated with triflic anhydride to afford the activated triflate (VIII). The regioselective condensation of (VIII) with 2-amino-6-iodopurine benzyltriethylammonium salt (IX) gives the expected addition product (X), which is debenzoylated with NaOMe in methanol yielding the 2-amino-6-methoxypurine (XI). Finally, this compound is converted to lobucavir by refluxing with aqueous hydrochloric acid.
【1】
Singh, J.; Bisacchi, G.S.; Ahmad, S.; et al.; A practical asymmetric synthesis of the antiviral agent lobucavir, BMS-180194. Org Process Res Dev 1998, 2, 6, 393.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(I) |
34029 |
bis[(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl] (E)-2-butenedioate
|
|
C24H40O4 |
详情 |
详情
|
(II) |
34030 |
1-methoxyvinyl methyl ether; 1,1-dimethoxyethylene
|
|
C4H8O2 |
详情 |
详情
|
(III) |
34031 |
bis[(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl] (1S,2R)-3,3-dimethoxy-1,2-cyclobutanedicarboxylate
|
|
C28H48O6 |
详情 |
详情
|
(IV) |
34032 |
[(1S,2S)-2-(hydroxymethyl)-3,3-dimethoxycyclobutyl]methanol
|
|
C8H16O4 |
详情 |
详情
|
(V) |
34033 |
[(1S,2S)-2-[(benzoyloxy)methyl]-3,3-dimethoxycyclobutyl]methyl benzoate
|
|
C22H24O6 |
详情 |
详情
|
(VI) |
14380 |
[(1S,2S)-2-[(benzoyloxy)methyl]-4-oxocyclobutyl]methyl benzoate
|
|
C20H18O5 |
详情 |
详情
|
(VII) |
14381 |
[(1S,2S,4S)-2-[(benzoyloxy)methyl]-4-hydroxycyclobutyl]methyl benzoate
|
|
C20H20O5 |
详情 |
详情
|
(VIII) |
14387 |
((1S,2S,4S)-2-[(benzoyloxy)methyl]-4-[[(trifluoromethyl)sulfonyl]oxy]cyclobutyl)methyl benzoate
|
|
C21H19F3O7S |
详情 |
详情
|
(IX) |
34036 |
2-Amino-6-iodo-6,9-dihydro-1H-purin-9-ide anion
|
|
C5H5IN5 |
详情 |
详情
|
(X) |
34034 |
[(1R,2R,4S)-2-(2-amino-6-iodo-1,6-dihydro-9H-purin-9-yl)-4-[(benzoyloxy)methyl]cyclobutyl]methyl benzoate
|
|
C25H24IN5O4 |
详情 |
详情
|
(XI) |
34035 |
[(1S,2R,3R)-3-(2-amino-6-methoxy-1,6-dihydro-9H-purin-9-yl)-2-(hydroxymethyl)cyclobutyl]methanol
|
|
C12H19N5O3 |
详情 |
详情
|
合成路线37
该中间体在本合成路线中的序号:
(LXIX) Tetrahydrofurfurylamine (XLVII) was converted into the corresponding phthalimide (XLVIII) by reaction of phthalic anhydride (V) in boiling chloroform. Subsequent ruthenium-catalyzed oxidation of (XLVIII) produced keto acid (XI), along with a pentanolide by-product, which was removed by column chromatography. Finally, acid hydrolysis of (XI) led to the desired compound. A closely related strategy was based in the ruthenium oxidation of N-benzoyl tetrahydrofurfurylamine (LXX), prepared from amine (XLVII) and benzoyl chloride (XLIX), to afford 5-benzoylaminolevulinic acid (XXXV), which was then hydrolyzed in boiling 6 N HCl .
【1】
Kawakami, H.; et al.; A new synthesis of 5-aminolevulinic acid. Agric Biol Chem 1991, 55, 6, 1687.
|
【2】
Matsumoto, K.; Kawakami, H.; Koseki, K.; Ebata, T.; Matsushita, H. (Japan Tobacco Inc.); Method of preparing an acid additional salt of delta-aminolevulinic acid. US 5284973 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(V) |
11900 |
2-Benzofuran-1,3-dione;1,2-Benzenedicarboxylic Anhydride;1,2-BENZENE DICARBOXYLIC ACID ANHYDRIDE;1,2-BENZENEDICARBONIC ACID, ANHYDRIDE;1,3-DIOXOPHTHALAN;1,3-ISOBENZOFURANDIONE;o-phthalic anhydride; Phthalic anhydride |
85-44-9 |
C8H4O3 |
详情 | 详情
|
(XI) |
59147 |
5-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-4-oxopentanoic acid
|
|
C13H11NO5 |
详情 |
详情
|
(XXXV) |
59156 |
5-(benzoylamino)-4-oxopentanoic acid
|
|
C12H13NO4 |
详情 |
详情
|
(LXVII) |
27335 |
Tetrahydro-2-furanylmethanamine; Tetrahydrofurfurylamine
|
4795-29-3 |
C5H11NO |
详情 | 详情
|
(LXVIII) |
59191 |
2-(tetrahydro-2-furanylmethyl)-1H-isoindole-1,3(2H)-dione
|
|
C13H13NO3 |
详情 |
详情
|
(LXIX) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(LXX) |
59192 |
N-(tetrahydro-2-furanylmethyl)benzamide
|
|
C12H15NO2 |
详情 |
详情
|
合成路线38
该中间体在本合成路线中的序号:
(II) Friedel-Crafts acylation of 4-hydroxy-1-phenyl[1,8]naphthyridin-2(1H)-one (I) with benzoyl chloride (II) using AlCl3 in hot nitrobenzene produced the 3-benzoyl naphthyridinone (III). This was cyclized to the title pyrazolonaphthyridinone by treatment with hydrazine in refluxing HOAc.
【1】
Suzuki, F.; Kawakita, T.; Kuroda, T.; Ohmori, K.; Nakajima, H.; Kamiya, T.; Tamaoki, T. (Kyowa Hakko Kogyo Co., Ltd.); Condensed naphthyridine derivs.. EP 0526840; JP 1993194515; US 5281610 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12018 |
4-Hydroxy-1-phenyl[1,8]naphthyridin-2(1H)-one
|
|
C14H10N2O2 |
详情 |
详情
|
(II) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(III) |
51629 |
3-benzoyl-4-hydroxy-1-phenyl[1,8]naphthyridin-2(1H)-one
|
|
C21H14N2O3 |
详情 |
详情
|
合成路线39
该中间体在本合成路线中的序号:
(XXIII) Compound (XIX) is condensed with 2-[1-(acetylsulfanylmethyl)cyclopropyl]acetic acid methyl ester (XX) by means of Cs2CO3 in acetonitrile yielding the expected condensation product (XXI). Finally, this compound is treated successively with pyridine and p-toluenesulfonic acid to eliminate the tetrahydropyranyl protecting group, and with NaOH to hydrolyzed the acetate ester group of (XXI).
4) The 2-[1-(acetylsulfanylmethyl)cyclopropyl]acetic acid methyl ester (XX) has been obtained as follows: The reduction of diethyl cyclopropane-1,1-dicarboxylate (XXII) with LiAlH4 in THF gives 1,1-cyclopropanedimethanol (XI), which is monobenzoylated with benzoyl chloride (XXIII) and pyridine in dichloromethane yielding benzoic acid 1-(hydroxymethyl)cyclopropylmethyl ester (XXIV). The mesylation of (XXIV) as usual affords the mesylate (XXV), which is treated with NaCN in DMSO to give 2-[1-(benzoyloxymethyl)cyclopropyl]acetonitrile (XXVI). The hydrolysis of (XXVI) with KOH in refluxing ethanol, followed by methylation with diazomethane, yields methyl 2-[1-(hydroxymethyl)cyclopropyl]acetate (XXVII), which is mesylated as usual affording the mesylate (XXIII). Finally, this compound is treated with cesium thiocetate in dichloromethane to give (XX).
【1】
Graul, A.; Martín, L.; Castañer, J.; Montelukast Sodium. Drugs Fut 1997, 22, 10, 1103. |
【2】
Labelle, M.; Belley, M.; Gareau, Y.; et al.; Discovery of MK-0476, a potent and orally active leukotriene D4 receptor antagonist devoid of peroxisomal enzyme induction. Bioorg Med Chem Lett 1995, 5, 3, 283-8.
|
【3】
Belley, M.L.; Leger, S.; Roy, P.; Xiang, Y.B.; Labelle, M.; Guay, D. (Merck Frosst Canada Inc.); Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists. EP 0480717; JP 1993105665 .
|
【4】
Bhupathy, M.; McNamara, J.M.; Sidler, D.R.; Volante, R.P.; Bergan, J.J. (Merck & Co., Inc.); Process for the preparation of leukotriene antagonists. WO 9518107 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XI) |
16533 |
[1-(hydroxymethyl)cyclopropyl]methanol
|
|
C5H10O2 |
详情 |
详情
|
(XVIII) |
16540 |
(1S)-1-[3-[(E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-[1-methyl-1-(tetrahydro-2H-pyran-2-yloxy)ethyl]phenyl]-1-propanol
|
|
C34H36ClNO3 |
详情 |
详情
|
(XIX) |
16541 |
(1S)-1-[3-[(E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-[1-methyl-1-(tetrahydro-2H-pyran-2-yloxy)ethyl]phenyl]propyl methanesulfonate
|
|
C35H38ClNO5S |
详情 |
详情
|
(XX) |
16542 |
methyl 2-[1-[(acetylsulfanyl)methyl]cyclopropyl]acetate
|
|
C9H14O3S |
详情 |
详情
|
(XXI) |
16543 |
methyl 2-(1-[[((1R)-1-[3-[(E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-[1-methyl-1-(tetrahydro-2H-pyran-2-yloxy)ethyl]phenyl]propyl)sulfanyl]methyl]cyclopropyl)acetate
|
|
C41H46ClNO4S |
详情 |
详情
|
(XXII) |
16544 |
diethyl 1,1-cyclopropanedicarboxylate
|
1559-02-0 |
C9H14O4 |
详情 | 详情
|
(XXIII) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(XXIV) |
16546 |
[1-(hydroxymethyl)cyclopropyl]methyl benzoate
|
|
C12H14O3 |
详情 |
详情
|
(XXV) |
16547 |
(1-[[(methylsulfonyl)oxy]methyl]cyclopropyl)methyl benzoate
|
|
C13H16O5S |
详情 |
详情
|
(XXVI) |
16548 |
[1-(cyanomethyl)cyclopropyl]methyl benzoate
|
|
C13H13NO2 |
详情 |
详情
|
(XXVII) |
16549 |
methyl 2-[1-(hydroxymethyl)cyclopropyl]acetate
|
|
C7H12O3 |
详情 |
详情
|
合成路线40
该中间体在本合成路线中的序号:
(XXI) In an alternative route, 2-N-acetyl-4,6-O-isopropylidene-D-glucosamine benzyl pyranoside (XVII) was alkylated with 1-bromo-2-butene (XVIII) in the presence of barium oxide and barium hydroxide to produce the 3-O-crotyl ether (XIX). After acidic hydrolysis of the isopropylidene ketal (XIX), the resultant diol (XX) was selectively mono-acylated at the primary hydroxyl with benzoyl chloride (XXI) to afford the 6-benzoate ester (XXII). Protection of the 3-hydroxyl group of (XXII) by means of dihydropyran (DHP) and p-toluenesulfonic acid gave rise to the tetrahydropyranyl ether (XXIII). After methanolysis of the benzoate ester of (XXIII) in the presence of NaOMe, the resultant primary alcohol (XXIV) was protected as the benzyl ether (XXV). Subsequent hydrolysis of the tetrahydropyranyl group of (XXV) in aqueous HOAc furnished the protected glucosamine intermediate (XXVI).
【1】
Kiso, M.; et al.; A general, convenient synthesis of the repeating, disaccharide-dipeptide unit of the bacterial, cell-wall peptidoglycan by the oxazoline method. Carbohydr Res 1980, 83, 1, C8.
|
【2】
Kiso, M.; et al.; Synthesis and immunoadjuvant activities of the repeating, disaccharide-dipeptide unit of the bacterial, cell-wall peptidoglycan and of some carbohydrate analogs. Carbohydr Res 1982, 104, 2, 253.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XVII) |
56337 |
N-[(4aR,6S,7R,8R,8aS)-6-(benzyloxy)-8-hydroxy-2,2-dimethylhexahydropyrano[3,2-d][1,3]dioxin-7-yl]acetamide
|
|
C18H25NO6 |
详情 |
详情
|
(XVIII) |
35252 |
(E)-1-bromo-2-butene
|
29576-14-5 |
C4H7Br |
详情 | 详情
|
(XIX) |
56338 |
N-{(4aR,6S,7R,8R,8aS)-6-(benzyloxy)-8-[(E)-2-butenyloxy]-2,2-dimethylhexahydropyrano[3,2-d][1,3]dioxin-7-yl}acetamide
|
|
C22H31NO6 |
详情 |
详情
|
(XX) |
56339 |
N-[(2S,3R,4R,5S,6R)-2-(benzyloxy)-4-[(E)-2-butenyloxy]-5-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl]acetamide
|
|
C19H27NO6 |
详情 |
详情
|
(XXI) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(XXII) |
56340 |
{(2R,3S,4R,5R,6S)-5-(acetylamino)-6-(benzyloxy)-4-[(E)-2-butenyloxy]-3-hydroxytetrahydro-2H-pyran-2-yl}methyl benzoate
|
|
C26H31NO7 |
详情 |
详情
|
(XXIII) |
56341 |
[(2R,3S,4R,5R,6S)-5-(acetylamino)-6-(benzyloxy)-4-[(E)-2-butenyloxy]-3-(tetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-2-yl]methyl benzoate
|
|
C31H39NO8 |
详情 |
详情
|
(XXIV) |
56342 |
N-[(2S,3R,4R,5S,6R)-2-(benzyloxy)-4-[(E)-2-butenyloxy]-6-(hydroxymethyl)-5-(tetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-3-yl]acetamide
|
|
C24H35NO7 |
详情 |
详情
|
(XXV) |
56343 |
N-[(2S,3R,4R,5S,6R)-2-(benzyloxy)-6-[(benzyloxy)methyl]-4-[(E)-2-butenyloxy]-5-(tetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-3-yl]acetamide
|
|
C31H41NO7 |
详情 |
详情
|
(XXVI) |
56344 |
N-{(2S,3R,4R,5S,6R)-2-(benzyloxy)-6-[(benzyloxy)methyl]-4-[(E)-2-butenyloxy]-5-hydroxytetrahydro-2H-pyran-3-yl}acetamide
|
|
C26H33NO6 |
详情 |
详情
|
合成路线41
该中间体在本合成路线中的序号:
(VIII) Treatment of 3,4-difluoroaniline (I) with CS2 and Et3N gives triethylammonium dithiocarbamate (II), which reacts with ethyl chloroformate in chloroform to yield (III). Isothiocyanate (III) is converted into the potassium salt (IV) by reaction with diethyl malonate and KOH in dioxane and then transformed into methoxymethyl thioether (VI) by means of reagent (V) and Et3N in toluene. Cyclization of (VI) by heating in diphenyl ether affords quinoline (VII), which then reacts with benzoyl chloride (VIII) in pyridine to furnish (IX). Benzoyloxy derivative (IX) is converted into (X) by means of HCl in EtOH, and its reaction with 1-bromo-2-fluoroethane (XI) and NaHCO3 yields compound (XII). Chlorination of (XII) with SO2Cl2 in hexane provides (XIII), which by simultaneous hydrolysis and intramolecular cyclization by means of Et3N /H2O in THF provides the mixture of isomers (XIV). (+)-(XV) is obtained by HPLC chromatography of (XIV) on a chiral stationary phase. Treatment of (+)-(XV) with 1-methylpiperazine (XVI) in DMF provides ethyl ester (+)-(XVII), which is finally hydrolyzed by means of H2SO4 in H2O.
【1】
Segawa, J.; Matsuoka, M.; Tomii, Y. (Nippon Shinyaku Co., Ltd.); Quinolinecarboxylic acid deriv. and process for producing the same. EP 0675127; WO 9414819 .
|
【2】
Kise, M.; Amimoto, I.; Kitano, M.; Segawa, J.; Tomii, Y.; Matsuoka, M.; Masui, Y.; Synthesis and antibacterial activity of novel 7-substituted-6-fluoro-1-fluoromethyl-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid derivatives. Chem Pharm Bull 1999, 47, 12, 1765. |
【3】
Segawa, J.; Kitano, M.; Kazuno, K.; Matsuoka, M.; Shirahase, I.; Ozaki, M.; Matsuda, M.; Tomii, Y.; Kise, M.; Studies on pyridonecarboxylic acids. 1. Synthesis and antibacterial evaluation of 7-substituted-6-halo-4-oxo-4H-[1,3]thiazeto[3, 2-a]quinoline-3-carboxylic acids. J Med Chem 1992, 35, 25, 4727. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13451 |
3,4-Difluoroaniline; 3,4-Difluorophenylamine
|
3863-11-4 |
C6H5F2N |
详情 | 详情
|
(II) |
42953 |
3,4-difluorophenylcarbamodithioic acid
|
|
C7H5F2NS2 |
详情 |
详情
|
(III) |
13453 |
1,2-Difluoro-4-isothiocyanatobenzene; 3,4-difluorophenyl isothiocyanate
|
113028-75-4 |
C7H3F2NS |
详情 | 详情
|
(IV) |
42954 |
potassium 1-(3,4-difluoroanilino)-3-ethoxy-2-(ethoxycarbonyl)-3-oxo-1-propene-1-thiolate
|
|
C14H14F2KNO4S |
详情 |
详情
|
(V) |
18319 |
Chloro(methoxy)methane; Chloromethyl methyl ether
|
107-30-2 |
C2H5ClO |
详情 | 详情
|
(VI) |
13455 |
diethyl 2-[(3,4-difluoroanilino)[(methoxymethyl)sulfanyl]methylene]malonate
|
|
C16H19F2NO5S |
详情 |
详情
|
(VII) |
13456 |
ethyl 6,7-difluoro-4-hydroxy-2-[(methoxymethyl)sulfanyl]-3-quinolinecarboxylate
|
|
C14H13F2NO4S |
详情 |
详情
|
(VIII) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(IX) |
42955 |
ethyl 4-(benzoyloxy)-6,7-difluoro-2-[(methoxymethyl)sulfanyl]-3-quinolinecarboxylate
|
|
C21H17F2NO5S |
详情 |
详情
|
(X) |
42956 |
ethyl 4-(benzoyloxy)-6,7-difluoro-2-sulfanyl-3-quinolinecarboxylate
|
|
C19H13F2NO4S |
详情 |
详情
|
(XI) |
28769 |
1-bromo-2-fluoroethane
|
762-49-2 |
C2H4BrF |
详情 | 详情
|
(XII) |
42957 |
ethyl 4-(benzoyloxy)-6,7-difluoro-2-[(2-fluoroethyl)sulfanyl]-3-quinolinecarboxylate
|
|
C21H16F3NO4S |
详情 |
详情
|
(XIII) |
42958 |
ethyl 4-(benzoyloxy)-2-[(1-chloro-2-fluoroethyl)sulfanyl]-6,7-difluoro-3-quinolinecarboxylate
|
|
C21H15ClF3NO4S |
详情 |
详情
|
(XIV) |
42959 |
ethyl 6,7-difluoro-1-(fluoromethyl)-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate
|
|
C14H10F3NO3S |
详情 |
详情
|
(XV) |
42960 |
ethyl (1R)-6,7-difluoro-1-(fluoromethyl)-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate
|
|
C14H10F3NO3S |
详情 |
详情
|
(XVI) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(XVII) |
42961 |
ethyl (1R)-6-fluoro-1-(fluoromethyl)-7-(4-methyl-1-piperazinyl)-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate
|
|
C19H21F2N3O3S |
详情 |
详情
|
合成路线42
该中间体在本合成路线中的序号:
(VIII) Treatment of 3,4-difluoroaniline (I) with CS2 and Et3N gives triethylammonium dithiocarbamate (II), which reacts with ethyl chloroformate in chloroform to yield (III). Isothiocyanate (III) is converted into the potassium salt (IV) by reaction with diethyl malonate and KOH in dioxane, and then transformed into methoxymethyl thioether (VI) by means of reagent (V) and Et3N in toluene. Cyclization of (VI) by heating in diphenyl ether affords quinoline (VII), which is then converted into (IX) by means of benzoyl chloride (VIII) in pyridine. Benzoyloxy derivative (IX) is converted into (X) by means of HCl in EtOH, and its reaction with 1-bromo-2-fluoroethane (XI) and NaHCO3 yields compound (XII). Chlorination of (XII) with SO2Cl2 in hexane provides (XIII), which by simultaneous hydrolysis and intramolecular cyclization by means of Et3N /H2O in THF provides the mixture of isomers (XIV). (-)-(XV) is then obtained by HPLC chromatography on a chiral stationary phase. Treatment of (-)-(XV) with 1-methylpiperazine (XVI) in DMF provides ethyl ester (-)-(XVII), which is finally hydrolyzed by means of H2SO4 in H2O.
【1】
Segawa, J.; Matsuoka, M.; Tomii, Y. (Nippon Shinyaku Co., Ltd.); Quinolinecarboxylic acid deriv. and process for producing the same. EP 0675127; WO 9414819 .
|
【2】
Kise, M.; Amimoto, I.; Kitano, M.; Segawa, J.; Tomii, Y.; Matsuoka, M.; Masui, Y.; Synthesis and antibacterial activity of novel 7-substituted-6-fluoro-1-fluoromethyl-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid derivatives. Chem Pharm Bull 1999, 47, 12, 1765. |
【3】
Segawa, J.; Kitano, M.; Kazuno, K.; Matsuoka, M.; Shirahase, I.; Ozaki, M.; Matsuda, M.; Tomii, Y.; Kise, M.; Studies on pyridonecarboxylic acids. 1. Synthesis and antibacterial evaluation of 7-substituted-6-halo-4-oxo-4H-[1,3]thiazeto[3, 2-a]quinoline-3-carboxylic acids. J Med Chem 1992, 35, 25, 4727. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13451 |
3,4-Difluoroaniline; 3,4-Difluorophenylamine
|
3863-11-4 |
C6H5F2N |
详情 | 详情
|
(II) |
42953 |
3,4-difluorophenylcarbamodithioic acid
|
|
C7H5F2NS2 |
详情 |
详情
|
(III) |
13453 |
1,2-Difluoro-4-isothiocyanatobenzene; 3,4-difluorophenyl isothiocyanate
|
113028-75-4 |
C7H3F2NS |
详情 | 详情
|
(IV) |
42954 |
potassium 1-(3,4-difluoroanilino)-3-ethoxy-2-(ethoxycarbonyl)-3-oxo-1-propene-1-thiolate
|
|
C14H14F2KNO4S |
详情 |
详情
|
(V) |
18319 |
Chloro(methoxy)methane; Chloromethyl methyl ether
|
107-30-2 |
C2H5ClO |
详情 | 详情
|
(VI) |
13455 |
diethyl 2-[(3,4-difluoroanilino)[(methoxymethyl)sulfanyl]methylene]malonate
|
|
C16H19F2NO5S |
详情 |
详情
|
(VII) |
13456 |
ethyl 6,7-difluoro-4-hydroxy-2-[(methoxymethyl)sulfanyl]-3-quinolinecarboxylate
|
|
C14H13F2NO4S |
详情 |
详情
|
(VIII) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(IX) |
42955 |
ethyl 4-(benzoyloxy)-6,7-difluoro-2-[(methoxymethyl)sulfanyl]-3-quinolinecarboxylate
|
|
C21H17F2NO5S |
详情 |
详情
|
(X) |
42956 |
ethyl 4-(benzoyloxy)-6,7-difluoro-2-sulfanyl-3-quinolinecarboxylate
|
|
C19H13F2NO4S |
详情 |
详情
|
(XI) |
28769 |
1-bromo-2-fluoroethane
|
762-49-2 |
C2H4BrF |
详情 | 详情
|
(XII) |
42957 |
ethyl 4-(benzoyloxy)-6,7-difluoro-2-[(2-fluoroethyl)sulfanyl]-3-quinolinecarboxylate
|
|
C21H16F3NO4S |
详情 |
详情
|
(XIII) |
42958 |
ethyl 4-(benzoyloxy)-2-[(1-chloro-2-fluoroethyl)sulfanyl]-6,7-difluoro-3-quinolinecarboxylate
|
|
C21H15ClF3NO4S |
详情 |
详情
|
(XIV) |
42959 |
ethyl 6,7-difluoro-1-(fluoromethyl)-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate
|
|
C14H10F3NO3S |
详情 |
详情
|
(XV) |
42971 |
octyl 2-[6,7-difluoro-1-(hydroxymethyl)-4-oxo-4H-[1,3]thiazeto[3,2-a]quinolin-3-yl]acetate
|
|
C21H25F2NO4S |
详情 |
详情
|
(XVI) |
10061 |
1-Methylpiperazine; 1-Methyl piperazine; N-Methylpiperazine
|
109-01-3 |
C5H12N2 |
详情 | 详情
|
(XVII) |
42975 |
ethyl (1S)-6-fluoro-1-(fluoromethyl)-7-(4-methyl-1-piperazinyl)-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate
|
|
C19H21F2N3O3S |
详情 |
详情
|
合成路线43
该中间体在本合成路线中的序号:
Condensation of ethyl 4-piperidinecarboxylate (I) with benzoyl chloride in pyridine afforded the corresponding benzamide (II). After reduction of the ester group of (II) with NaBH4, the resulting alcohol (III) was converted to chloride (IV) by means of SOCl2. Elimination of the chlorine atom of (IV) with potassium tert-butoxide produced N-benzoyl-4-methylenepiperidine (V), which was hydrolyzed with KOH to yield 4-methylenepiperidine (VI). Finally, condensation of (VI) with the known epoxide (VII) in refluxing EtOH furnished the title compound.
【1】
Ogura, H.; et al.; Synthesis and antifungal activities of (2R,3R)-2-aryl-1-azolyl-3-(substituted amino)-2-butanol derivatives as topical antifungal agents. Chem Pharm Bull 1999, 47, 10, 1417.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(I) |
17410 |
Ethyl isonipecotate; ethyl 4-piperidinecarboxylate
|
1126-09-6 |
C8H15NO2 |
详情 | 详情
|
(II) |
31733 |
ethyl 1-benzoyl-4-piperidinecarboxylate
|
|
C15H19NO3 |
详情 |
详情
|
(III) |
31734 |
[4-(hydroxymethyl)-1-piperidinyl](phenyl)methanone
|
|
C13H17NO2 |
详情 |
详情
|
(IV) |
31735 |
[4-(chloromethyl)-1-piperidinyl](phenyl)methanone
|
|
C13H16ClNO |
详情 |
详情
|
(V) |
31736 |
(4-methylene-1-piperidinyl)(phenyl)methanone
|
|
C13H15NO |
详情 |
详情
|
(VI) |
31737 |
4-methylenepiperidine
|
|
C6H11N |
详情 |
详情
|
(VII) |
31738 |
1-[[(2R,3S)-2-(2,4-difluorophenyl)-3-methyloxiranyl]methyl]-1H-1,2,4-triazole
|
|
C12H11F2N3O |
详情 |
详情
|
合成路线44
该中间体在本合成路线中的序号:
(X) Treatment of carboxylic acid (I) with refluxing cyclohexanone (II) and H2SO4 affords derivative (III), which is then condensed with propargyl bromide (IV) by means of NaH in DMF to yield propargyl ether (V). Treatment of (V) with Et3N in toluene followed by condensation with 4-cloro-iodobenzene (VI) by means of PdCl2, PPh3 and CuI provides propinyloxy derivative (VII), which is then converted into propenyloxy derivative (VIII) by hydrogenation over Pd/ BaSO4 in pyridine. Opening of the lactone ring of (VIII) by means of NaH in MeOH and THF affords methyl ester (IX), which is then condensed with benzoyl chloride (X) by means of DMAP and Et3N in CH2Cl2 to give benzoate (XI). Treatment of (XI) with Et2Zn and chloroiodomethane in dichloroethane (or alternatively in CH2Cl2 or THF) followed by recrystallization from isopropanol furnishes cyclopropane derivative (XII), which is then hydrolyzed by treatment with NaOH in dioxane to yield alcohol (XIII). Finally, (XIII) is condensed with intermediate (XIV) by means of NaH in DMF and then deprotected by treatment with HCl in dioxane to afford the target compound.
【1】
Hemmerle, H.; Schindler, P.; Herling, A. (Aventis SA); Derivs. of substd. cyclohexane, their process of preparation and their application for the treatment of diseases. EP 0587088; JP 1994211736; US 5463062 .
|
【2】
Hemmerle, H.; Schubert, G.; Burger, H.-J.; Herling, A.; Efendic, S. (Aventis SA); Cyclohexane derivs., processes for their preparation and their use as glucose-6-phosphatase inhibitors. CA 2149007; CA 4416433; EP 0682024; JP 1995330767; US 5739147 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
44864 |
Quinic acid; 1,3,4,5-tetrahydroxycyclohexanecarboxylic acid
|
|
C7H12O6 |
详情 |
详情
|
(II) |
11059 |
Cyclohexanone
|
108-94-1 |
C6H10O |
详情 | 详情
|
(III) |
44855 |
|
|
C13H18O5 |
详情 |
详情
|
(IV) |
11176 |
3-Bromopropyne; 3-Bromo-1-propyne
|
106-96-7 |
C3H3Br |
详情 | 详情
|
(V) |
44856 |
|
|
C16H20O5 |
详情 |
详情
|
(VI) |
19395 |
1-chloro-4-iodobenzene
|
637-87-6 |
C6H4ClI |
详情 | 详情
|
(VII) |
44857 |
|
|
C22H23ClO5 |
详情 |
详情
|
(VIII) |
44858 |
|
|
C22H25ClO5 |
详情 |
详情
|
(IX) |
44859 |
|
|
C23H29ClO6 |
详情 |
详情
|
(X) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(XI) |
44860 |
|
|
C30H33ClO7 |
详情 |
详情
|
(XII) |
44861 |
|
|
C31H35ClO7 |
详情 |
详情
|
(XIII) |
44862 |
|
|
C23H29ClO6 |
详情 |
详情
|
(XIV) |
44863 |
|
|
C17H12N6O |
详情 |
详情
|
合成路线45
该中间体在本合成路线中的序号:
Wittig reaction of 2,4-O-benzylidene-D-threose (I) with the phosphorane derived from tetradecyl triphenyl phosphonium salt (II) provided the trans olefin (III). After conversion of hydroxyl group of (III) into the corresponding triflate, displacement with NaN3 yielded azide (IV) with inversion of configuration. Acid hydrolysis of the benzylidene acetal of (IV) gave diol (V). Then, selective protection of the primary hydroxyl group with tert-butyldimethylsilyl chloride produced silyl ether (VI). Subsequent benzoylation of the remaining hydroxyl group of (VI) gave benzoate ester (VII). The silyl protecting group of (VII) was then removed using tetra n-butylammonium fluoride in THF to give azido alcohol (VIII). This was coupled with tetraacetyl-D-galactosyl bromide (IX) to give the corresponding galactopyranoside (X) as an epimeric mixture. After chromatographic separation of the major beta-anomer, removal of the acetyl protecting groups with sodium methoxide yielded (XI).
【1】
Banville, J.; Martel, A.; Aruffo, A.A. (Bristol-Myers Squibb Co.); Sulfated beta-glycolipid derivs. as cell adhesion inhibitors. EP 0671406; JP 1995285985; US 5565433 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(I) |
26505 |
(2S,4S,5R)-5-hydroxy-2-phenyl-1,3-dioxane-4-carbaldehyde
|
|
C11H12O4 |
详情 |
详情
|
(II) |
26506 |
triphenyl(tetradecyl)phosphorane
|
|
C32H45P |
详情 |
详情
|
(III) |
26507 |
(2S,4R,5R)-4-[(Z)-1-pentadecenyl]-2-phenyl-1,3-dioxan-5-ol
|
|
C25H40O3 |
详情 |
详情
|
(IV) |
26508 |
(2S,4R,5S)-4-[(Z)-1-pentadecenyl]-2-phenyl-1,3-dioxan-5-yl azide
|
|
C25H39N3O2 |
详情 |
详情
|
(V) |
26509 |
(2S,3R,4Z)-2-azido-4-octadecene-1,3-diol
|
|
C18H35N3O2 |
详情 |
详情
|
(VI) |
26510 |
(2S,3R,4Z)-2-azido-1-[[tert-butyl(dimethyl)silyl]oxy]-4-octadecen-3-ol
|
|
C24H49N3O2Si |
详情 |
详情
|
(VII) |
26511 |
(1R,2Z)-1-((1S)-1-azido-2-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-2-hexadecenyl benzoate
|
|
C31H53N3O3Si |
详情 |
详情
|
(VIII) |
26512 |
(1R,2Z)-1-[(1S)-1-azido-2-hydroxyethyl]-2-hexadecenyl benzoate
|
|
C25H39N3O3 |
详情 |
详情
|
(IX) |
26513 |
(2R,3R,4S,5R,6R)-3,5-bis(acetoxy)-2-[(acetoxy)methyl]-6-bromotetrahydro-2H-pyran-4-yl acetate
|
3068-32-4 |
C14H19BrO9 |
详情 | 详情
|
(X) |
26514 |
(1R,2Z)-1-[(1S)-1-azido-2-([(3R,4S,5S,6R)-3,4,5-tris(acetoxy)-6-[(acetoxy)methyl]tetrahydro-2H-pyran-2-yl]oxy)ethyl]-2-hexadecenyl benzoate
|
|
C39H57N3O12 |
详情 |
详情
|
(XI) |
26515 |
(1R,2Z)-1-((1S)-1-azido-2-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy]ethyl)-2-hexadecenyl benzoate
|
|
C31H49N3O8 |
详情 |
详情
|
合成路线46
该中间体在本合成路线中的序号:
Protection of the 4- and 6-hydroxyl groups of (XI) was achieved by conversion into the benzylidene acetal (XII) upon treatment with benzaldehyde and formic acid. The remaining 2- and 3-hydroxyl groups of (XII) were benzoylated with benzoyl chloride to afford the corresponding benzoate ester (XIII). After reduction of the azide group of (XIII) to amine (XIV) with H2S and pyridine, condensation with hexadecanoyl chloride produced the corresponding amide (XV). Deprotection of the acetal group of (XV) with TFA in CH2Cl2 gave diol (XVI), which was finally treated with SO3-Me3N complex, and then with NaHCO3 to form the title disulfate sodium salt.
【1】
Banville, J.; Martel, A.; Aruffo, A.A. (Bristol-Myers Squibb Co.); Sulfated beta-glycolipid derivs. as cell adhesion inhibitors. EP 0671406; JP 1995285985; US 5565433 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
|
10498 |
Benzaldehyde;Benzoic aldehyde;Phenylmethanal |
100-52-7 |
C7H6O |
详情 | 详情
|
|
16480 |
Palmitoyl Chloride; hexadecanoyl chloride
|
112-67-4 |
C16H31ClO |
详情 | 详情
|
(XI) |
26515 |
(1R,2Z)-1-((1S)-1-azido-2-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy]ethyl)-2-hexadecenyl benzoate
|
|
C31H49N3O8 |
详情 |
详情
|
(XII) |
26516 |
(1R,2Z)-1-((1S)-2-[[(2S,4aR,6S,7R,8R,8aR)-7,8-dihydroxy-2-phenylhexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-1-azidoethyl)-2-hexadecenyl benzoate
|
|
C38H53N3O8 |
详情 |
详情
|
(XIII) |
26517 |
(1R,2Z)-1-((1S)-2-[[(2S,4aR,6S,7R,8S,8aS)-7,8-bis(benzoyloxy)-2-phenylhexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-1-azidoethyl)-2-hexadecenyl benzoate
|
|
C52H61N3O10 |
详情 |
详情
|
(XIV) |
26518 |
(1R,2Z)-1-((1S)-2-[[(2S,4aR,6S,7R,8S,8aS)-7,8-bis(benzoyloxy)-2-phenylhexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-1-aminoethyl)-2-hexadecenyl benzoate
|
|
C52H63NO10 |
详情 |
详情
|
(XV) |
26519 |
(1R,2Z)-1-[(1S)-2-[[(2S,4aR,6S,7R,8S,8aS)-7,8-bis(benzoyloxy)-2-phenylhexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-1-(palmitoylamino)ethyl]-2-hexadecenyl benzoate
|
|
C68H93NO11 |
详情 |
详情
|
(XVI) |
26520 |
(1R,2Z)-1-[(1S)-2-[[(2S,3R,4S,5S,6R)-3,4-bis(benzoyloxy)-5-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy]-1-(palmitoylamino)ethyl]-2-hexadecenyl benzoate
|
|
C61H89NO11 |
详情 |
详情
|
合成路线47
该中间体在本合成路线中的序号:
(III) The reaction of bromobenzene (I) with 14CO2 by means of Mg in ether gives the corresponding benzoic acid (II), which is treated with SOCl2 and DMAP to yield the benzoyl chloride (III). The homologation of (III) with diazomethane in ether affords the phenacyl chloride (IV), which is enantioselectively reduced with borane and a chiral borolidine catalyst in THF to give (R)-2-chloro-1-phenylethanol (V). The cyclization of (V) by means of NaOH in ethyl ether yields the oxirane (VI), which by reaction with ammonia is converted into the (R)-2-amino-1-phenylethanol (VII). The condensation of (VII) with 4'-chlorobiphenyl-4-carboxylic acid (VIII) by means of CDI in DMF provides the amide (IX), which is cyclized to the oxazoline (X) by means of methanesulfonic anhydride and TEA in THF. Finally, this compound is condensed with imidazole (XI) by heating at 125 C.
【1】
Moenius, T.; et al.; C-14 labelling of NVPVID400 - a specific vitamin D-3-hydroxylase inhibitor. J Label Compd Radiopharm 1999, 42, 11, 1053.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13365 |
Monobromobenzene; 1-Bromobenzene;Phenylbromide;bromobenzene |
108-86-1 |
C6H5Br |
详情 | 详情
|
(II) |
10202 |
Benzoic acid
|
65-85-0 |
C7H6O2 |
详情 | 详情
|
(III) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(IV) |
38669 |
2-chloro-1-phenyl-1-ethanone
|
532-27-4 |
C8H7ClO |
详情 | 详情
|
(V) |
38670 |
(1R)-2-chloro-1-phenyl-1-ethanol
|
1674-30-2 |
C8H9ClO |
详情 | 详情
|
(VI) |
38671 |
(2R)-2-phenyloxirane
|
|
C8H8O |
详情 |
详情
|
(VII) |
10173 |
(1R)-2-Amino-1-phenyl-1-ethanol
|
2549-14-6 |
C8H11NO |
详情 | 详情
|
(VIII) |
38672 |
4'-chloro[1,1'-biphenyl]-4-carboxylic acid
|
|
C13H9ClO2 |
详情 |
详情
|
(IX) |
38673 |
4'-chloro-N-[(2R)-2-hydroxy-2-phenylethyl][1,1'-biphenyl]-4-carboxamide
|
|
C21H18ClNO2 |
详情 |
详情
|
(X) |
38674 |
(5S)-2-(4'-chloro[1,1'-biphenyl]-4-yl)-5-phenyl-4,5-dihydro-1,3-oxazole
|
|
C21H16ClNO |
详情 |
详情
|
(XI) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
合成路线48
该中间体在本合成路线中的序号:
(X) The reaction of 2-bromoethanol (I) with dihydropyran by means of a strong acid ion exchange resin gives the tetrahydropyranyl ether (II), which is condensed with 2-(3,4-dichlorophenyl)acetonitrile (III) by means of NaH in THF yielding thebutyronitrile (IV). The reduction of (IV) with H2 over RaNi in ethanol/NH4OH affords the butylamine (V), which is deprotected with HCl in methanol providing racemic 2-(3,4-dichlorophenyl)-4-hydroxybutylamine (VI). The optical resolution of (VI) with D-tartaric acid affords the corresponding (S) isomer (VII), which is treated with ethyl chloroformate and triethylamine in dichloromethane to give the carbamate (VIII). The reduction of (VIII) with LiAlH4 in THF yields N-[2(S)-(3,4-dichlorophenyl)-4-hydroxybutyl]-N-methylamine (IX), which is acylated with benzoyl chloride (X) and triethylamine in dichloromethane to affords the amide (XI). Oxidation of the hydroxyl group of (XI) with Dess-Martin periodinane yields the corresponding aldehyde (XII), which is reductocondensed with 4-[N-(trifluoroacetyl)-N-[3-(trifluoroacetamido)propyl]amino]piperidine (XIII) by means of NaBH3CN in methanol/acetic acid providing the bis(trifluoroacetylated) intermediate (XIV). The deprotection of (XIV) with KOH in methanol/water gives the diamine intermediate (XV), which is finally cyclized with carbonyldiimidazole (CDI) in chloroform.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10059 |
Ethylene bromohydrin; 2-Bromo-1-ethanol
|
540-51-2 |
C2H5BrO |
详情 | 详情
|
(II) |
26934 |
2-bromoethyl tetrahydro-2H-pyran-2-yl ether
|
|
C7H13BrO2 |
详情 |
详情
|
(III) |
26935 |
2-(3,4-dichlorophenyl)acetonitrile
|
3218-49-3 |
C8H5Cl2N |
详情 | 详情
|
(IV) |
26936 |
2-(3,4-dichlorophenyl)-4-(tetrahydro-2H-pyran-2-yloxy)butanenitrile
|
|
C15H17Cl2NO2 |
详情 |
详情
|
(V) |
26937 |
2-(3,4-dichlorophenyl)-4-(tetrahydro-2H-pyran-2-yloxy)-1-butanamine
|
|
C15H21Cl2NO2 |
详情 |
详情
|
(VI) |
26938 |
4-amino-3-(3,4-dichlorophenyl)-1-butanol
|
|
C10H13Cl2NO |
详情 |
详情
|
(VII) |
26939 |
(3S)-4-amino-3-(3,4-dichlorophenyl)-1-butanol
|
|
C10H13Cl2NO |
详情 |
详情
|
(VIII) |
26940 |
ethyl (2S)-2-(3,4-dichlorophenyl)-4-hydroxybutylcarbamate
|
|
C13H17Cl2NO3 |
详情 |
详情
|
(IX) |
26941 |
(3S)-3-(3,4-dichlorophenyl)-4-(methylamino)-1-butanol
|
|
C11H15Cl2NO |
详情 |
详情
|
(X) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(XI) |
26942 |
N-[(2S)-2-(3,4-dichlorophenyl)-4-hydroxybutyl]-N-methylbenzamide
|
|
C18H19Cl2NO2 |
详情 |
详情
|
(XII) |
26943 |
N-[(2S)-2-(3,4-dichlorophenyl)-4-oxobutyl]-N-methylbenzamide
|
|
C18H17Cl2NO2 |
详情 |
详情
|
(XIII) |
26944 |
2,2,2-trifluoro-N-(4-piperidinyl)-N-[3-[(2,2,2-trifluoroacetyl)amino]propyl]acetamide
|
|
C12H17F6N3O2 |
详情 |
详情
|
(XIV) |
26945 |
N-[(2S)-2-(3,4-dichlorophenyl)-4-[4-((2,2,2-trifluoroacetyl)[3-[(2,2,2-trifluoroacetyl)amino]propyl]amino)-1-piperidinyl]butyl]-N-methylbenzamide
|
|
C30H34Cl2F6N4O3 |
详情 |
详情
|
(XV) |
26946 |
N-[(2S)-4-[4-[(3-aminopropyl)amino]-1-piperidinyl]-2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide
|
|
C26H36Cl2N4O |
详情 |
详情
|
合成路线49
该中间体在本合成路线中的序号:
(II) YM-905 has been obtained by two related ways:
1) The benzoylation of 2-phenylethylamine (I) with benzoyl chloride (II) and triethylamine in chloroform, or with benzoic acid (III), DPPA and triethylamine in DMF, gives the corresponding benzamide (IV), which is cyclized by means of POCl3 and P2O5 in refluxing xylene and reduced with NaBH4 in ethanol, yielding racemic 1-phenyl-1,2,3,4-tetrahydroisoquinoline (V). The reaction of (V) with ethyl chloroformate by means of K2CO3 in chloroform affords racemic 1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid ethyl ester (VI), which is transesterified with quinuclidine-3(R)-ol (VII) by means of NaH in refluxing toluene to provide the quinuclidinyl ester (VIII) as a diastereomeric mixture. This mixture is resolved by chiral HPLC, giving the target compound as a pure enantiomer.
2) The racemic 1-phenyl-1,2,3,4-tetrahydroisoquinoline (V) can also be submitted to optical resolution with (+)-tartaric acid to give 1(S)-phenyl-1,2,3,4-tetrahydroisoquinoline (IX), which is condensed with ethyl chloroformate by means of K2CO3 in chloroform to afford 1(S)-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid ethyl ester (VI). This compound is transesterified with quinuclidine-3(R)-ol (VII) by means of NaH in refluxing toluene to directly provide the pure enantiomer.
【1】
Mealy, N.; Castañer, J.; YM-905. Drugs Fut 1999, 24, 8, 871.
|
【2】
Takeuchi, M.; Naito, R.; Hayakawa, M.; Okamoto, Y.; Yonetoku, Y.; Ikeda, K.; Isomura, Y. (Yamanouchi Pharmaceutical Co., Ltd.); Novel quinuclidine derivs. and medicinal compsn. thereof. EP 0801067; US 6017927; WO 9620194 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
18333 |
Phenethylamine; 2-Phenyl-1-ethanamine
|
64-04-0 |
C8H11N |
详情 | 详情
|
(II) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(III) |
10202 |
Benzoic acid
|
65-85-0 |
C7H6O2 |
详情 | 详情
|
(IV) |
26007 |
N-phenethylbenzamide
|
|
C15H15NO |
详情 |
详情
|
(V) |
26008 |
1-phenyl-1,2,3,4-tetrahydroisoquinoline
|
|
C15H15N |
详情 |
详情
|
(VI) |
26009 |
ethyl 1-phenyl-3,4-dihydro-2(1H)-isoquinolinecarboxylate
|
|
C18H19NO2 |
详情 |
详情
|
(VII) |
16152 |
(3R)-1-azabicyclo[2.2.2]octan-3-ol; (R)-(-)-Quinuclidinol
|
42437-96-7 |
C7H13NO |
详情 | 详情
|
(VIII) |
26010 |
(3R)-1-azabicyclo[2.2.2]oct-3-yl 1-phenyl-3,4-dihydro-2(1H)-isoquinolinecarboxylate
|
|
C23H26N2O2 |
详情 |
详情
|
(IX) |
26011 |
(1S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline
|
|
C15H15N |
详情 |
详情
|
(X) |
26012 |
ethyl (1S)-1-phenyl-3,4-dihydro-2(1H)-isoquinolinecarboxylate
|
|
C18H19NO2 |
详情 |
详情
|
合成路线50
该中间体在本合成路线中的序号:
(XI) Benzamide (XII) was prepared by acylation of morpholine (X) with benzoyl chloride (XI). The benzoate ester of (XII) was subsequently hydrolyzed under basic conditions to the alcohol (XIII), which was further converted to the mesylate ester (XIV) by means of methanesulfonyl chloride and triethylamine.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(X) |
54989 |
2-[(2R)-2-(3,4-difluorophenyl)morpholinyl]ethyl benzoate
|
|
C19H19F2NO3 |
详情 |
详情
|
(XI) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(XII) |
54990 |
2-[(2R)-4-benzoyl-2-(3,4-difluorophenyl)morpholinyl]ethyl benzoate
|
|
C26H23F2NO4 |
详情 |
详情
|
(XIII) |
54991 |
[(2R)-2-(3,4-difluorophenyl)-2-(2-hydroxyethyl)morpholinyl](phenyl)methanone
|
|
C19H19F2NO3 |
详情 |
详情
|
(XIV) |
54992 |
2-[(2R)-4-benzoyl-2-(3,4-difluorophenyl)morpholinyl]ethyl methanesulfonate
|
|
C20H21F2NO5S |
详情 |
详情
|
合成路线51
该中间体在本合成路线中的序号:
(D) Ethyl 2,3-dibromopropionate (I) is condensed with N-tosyl-O-benzylhydroxylamine (A) by means of NaOEt in ethanol to give after a treatment with ammonia, propionic acid (II), which is detosylated by treatment with phenol and 36% HBr- yielding D,L-2-amino-3-(benzyloxyamino)propionic acid (III). The benzoylation of (III) with N-benzoyloxysuccinimide (B) by means of Triton B - in methanol affords D,L-2-benzoylamino-3-benzyloxyaminopropionic acid (IV), which is resolved into its optical isomers by treatment with aniline (C) and papain in 0.5M NaOH - 0.5M citric acid and L-cysteine hydrochloride; L-2-benzoylamino-3-benzyloxyaminopropionanilide (L)-(V) was isolated. The benzoylation of (L)-(V) with benzoyl chloride (D) in pyridine affords L-2-benzoylamino-3-(N-benzoyl-N-benzyloxyamino)propionanilide (L)-(VI), which is debenzylated by hydrogenation with H2 over Pd/C in methanol giving L-2-benzoylamino-3-(N-benzoyl-N-hydroxyamino)propionanilide (L)-(VII). The protecting groups of (L)-(VII) are eliminated by treatment with 6M HCl at 90-5 C yielding L-2-amino-3-hydroxyaminopropionic acid (L)-(VIII), which is finally nitrosated with NaNO2 and HCl.
【1】
Serradell, M.N.; Castañer, J.; Cabanillas, F.; Blancafort, P.; Alanosine. Drugs Fut 1979, 4, 7, 469.
|
【2】
Yoshikazu, I.; et al.; Synthesis of alanosine. Bull Chem Soc Jpn 1973, 46, 1847-50.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(D) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(A) |
39517 |
N-(benzyloxy)-4-methylbenzenesulfonamide
|
|
C14H15NO3S |
详情 |
详情
|
(B) |
39520 |
1-(benzoyloxy)-2,5-pyrrolidinedione
|
|
C11H9NO4 |
详情 |
详情
|
(L)-(V) |
39522 |
N-((1S)-2-anilino-1-[[(benzyloxy)amino]methyl]-2-oxoethyl)benzamide
|
|
C23H23N3O3 |
详情 |
详情
|
(L)-(VI) |
39523 |
N-[(2S)-3-anilino-3-oxo-2-(propionylamino)propyl]-N-(benzyloxy)benzamide
|
|
C26H27N3O4 |
详情 |
详情
|
(L)-(VII) |
39524 |
N-((1S)-2-anilino-1-[[benzoyl(hydroxy)amino]methyl]-2-oxoethyl)benzamide
|
|
C23H21N3O4 |
详情 |
详情
|
(L)-(VIII) |
39525 |
(2S)-2-amino-3-(hydroxyamino)propionic acid
|
|
C3H8N2O3 |
详情 |
详情
|
(I) |
18341 |
ethyl 2,3-dibromopropanoate
|
3674-13-3 |
C5H8Br2O2 |
详情 | 详情
|
(II) |
39518 |
3-[(benzyloxy)[(4-methylphenyl)sulfonyl]amino]alanine
|
|
C17H20N2O5S |
详情 |
详情
|
(III) |
39519 |
3-[(benzyloxy)amino]alanine
|
|
C10H14N2O3 |
详情 |
详情
|
(IV) |
39521 |
N-benzoyl-3-[(benzyloxy)amino]alanine
|
|
C17H18N2O4 |
详情 |
详情
|
(C) |
12294 |
Aniline; Phenylamine
|
62-53-3 |
C6H7N |
详情 | 详情
|
合成路线52
该中间体在本合成路线中的序号:
The oxidation of 1-O-mehyl 2,3-isopropylidene-D-ribofuranoside (I) gives the corresponding aldehyde (II), which is condensed with methyltriphenylphosphonium bromide by means of butyllithium in THF yielding methyl 5-deoxy-2,3-isopropylidene-5-methylene-D-ribofuranoside (III). Elimination of the isopropylidene protecting group by passing through an Amberlyst resin (acid form) affords the free ribofuranoside (IV), which is benzoylated with benzoyl chloride and triethylamine in dichloromethane to afford the dibenzoyl derivative (V). The methyl ribofuranoside (V) was converted into the 1-O-acetyl derivative (VI) and condensed with 2,6-dichloro-9H-purine (VII) by heating at 150 C to provide the dichloropurine derivative (VIII), which is treated with O-methylhydroxylamine and triethylamine to afford 2',3'-di-O-benzoyl-2-chloro-5'-deoxy-N-methoxy-5'-methyleneadenosine (IX). Finally, this compound is debenzoylated with ammonia in methanol.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
|
15455 |
(aminooxy)methane; O-methylhydroxylamine
|
67-62-9 |
CH5NO |
详情 | 详情
|
(I) |
10017 |
[(3aR,4R,6R,6aR)-6-Methoxy-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl]methanol
|
4099-85-8 |
C9H16O5 |
详情 | 详情
|
(II) |
10018 |
(3aR,4S,6R,6aR)-6-Methoxy-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxole-4-carbaldehyde
|
|
C9H14O5 |
详情 |
详情
|
(III) |
25257 |
(3aS,4R,6R,6aR)-4-methoxy-2,2-dimethyl-6-vinyltetrahydrofuro[3,4-d][1,3]dioxole; (3aS,4R,6R,6aR)-2,2-dimethyl-6-vinyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl methyl ether
|
|
C10H16O4 |
详情 |
详情
|
(IV) |
25258 |
(2R,3S,4S,5R)-2-methoxy-5-vinyltetrahydro-3,4-furandiol
|
|
C7H12O4 |
详情 |
详情
|
(V) |
25259 |
(2R,3R,4R,5R)-4-(benzoyloxy)-2-methoxy-5-vinyltetrahydro-3-furanyl benzoate
|
|
C21H20O6 |
详情 |
详情
|
(VI) |
25260 |
(2R,3R,4R,5S)-5-(acetoxy)-4-(benzoyloxy)-2-vinyltetrahydro-3-furanyl benzoate
|
|
C22H20O7 |
详情 |
详情
|
(VII) |
25254 |
2,6-dichloro-9H-purine
|
5451-40-1 |
C5H2Cl2N4 |
详情 | 详情
|
(VIII) |
25261 |
(2R,3R,4S,5R)-4-(benzoyloxy)-2-(2,6-dichloro-9H-purin-9-yl)-5-vinyltetrahydro-3-furanyl benzoate
|
|
C25H18Cl2N4O5 |
详情 |
详情
|
(IX) |
25262 |
(2R,3R,4S,5R)-4-(benzoyloxy)-2-[2-chloro-6-(methoxyamino)-9H-purin-9-yl]-5-vinyltetrahydro-3-furanyl benzoate
|
|
C26H22ClN5O6 |
详情 |
详情
|
合成路线53
该中间体在本合成路线中的序号:
The cyclization of ribofuranoside (I) with trimethylsilyl acetylene (II) by means of NBS in DMF gives the trimethylsilylisoxazole (III), which is desilylated with NaOH in methanol yielding the isoxazole (IV). Elimination of the isopropylidene protecting group of (IV) by passing through a Dowex 50 H+ column affords the dihydroxy compound (V), which is benzoylated with benzoyl chloridde and DMAP in pyridine giving the dibenzoyl derivative (VI). The condensation of (VI) with 2,6-dichloro-9H-purine (VII) in refluxing hexamethyldisilazane (HMDA) provides the purine derivative (VIII), which is treated with 0-methylhydroxylamine and triethylamine in refluxing dioxane yielding the adenosine derivative (IX). Finally, this compound is debenzoylated with ammonia in methanol.
【1】
Knutsen, L.; Olsen, U.B.; Roberts, S.M.; Varley, D.R.; Bowler, A.N. (Novo Nordisk A/S); Novel N-alkoxyadenine derivs. acting as cytokine inhibitors. WO 9801459 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
|
15455 |
(aminooxy)methane; O-methylhydroxylamine
|
67-62-9 |
CH5NO |
详情 | 详情
|
(I) |
25249 |
(3aR,4R,6R,6aS)-6-methoxy-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxole-4-carbaldehyde O-methyloxime
|
|
C10H17NO5 |
详情 |
详情
|
(II) |
23897 |
ethynyl(trimethyl)silane;trimethylsilyl acetylene |
1066-54-2 |
C5H10Si |
详情 | 详情
|
(III) |
25250 |
3-[(3aR,4R,6R,6aS)-6-methoxy-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl]-5-(trimethylsilyl)isoxazole; (3aS,4R,6R,6aR)-2,2-dimethyl-6-[5-(trimethylsilyl)-3-isoxazolyl]tetrahydrofuro[3,4-d][1,3]dioxol-4-yl methyl ether
|
|
C14H23NO5Si |
详情 |
详情
|
(IV) |
25251 |
3-[(3aR,4R,6R,6aS)-6-methoxy-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl]isoxazole; (3aS,4R,6R,6aR)-6-(3-isoxazolyl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl methyl ether
|
|
C11H15NO5 |
详情 |
详情
|
(V) |
25252 |
(2R,3S,4S,5R)-2-(3-isoxazolyl)-5-methoxytetrahydro-3,4-furandiol
|
|
C8H11NO5 |
详情 |
详情
|
(VI) |
25253 |
(2R,3R,4R,5R)-4-(benzoyloxy)-2-(3-isoxazolyl)-5-methoxytetrahydro-3-furanyl benzoate
|
|
C22H19NO7 |
详情 |
详情
|
(VII) |
25254 |
2,6-dichloro-9H-purine
|
5451-40-1 |
C5H2Cl2N4 |
详情 | 详情
|
(VIII) |
25255 |
(2R,3R,4S,5R)-4-(benzoyloxy)-2-(2,6-dichloro-9H-purin-9-yl)-5-(3-isoxazolyl)tetrahydro-3-furanyl benzoate
|
|
C26H17Cl2N5O6 |
详情 |
详情
|
(IX) |
25256 |
(2R,3R,4S,5R)-4-(benzoyloxy)-2-[2-chloro-6-(methoxyamino)-9H-purin-9-yl]-5-(3-isoxazolyl)tetrahydro-3-furanyl benzoate
|
|
C27H21ClN6O7 |
详情 |
详情
|
合成路线54
该中间体在本合成路线中的序号:
(V) Condensation between 5-bromoindole (I) in ether and oxalyl chloride (II) in dichloromethane followed by treatment with dimethylamine provides N,N-dimethyaminoglyoxyl derivative (III), which is then reduced with LiAlH4 in THF to yield compound (IV). Coupling of (IV) with benzoyl chloride (V) by means of Et3N and DMAP in dichloromethane affords benzoylindole derivative (VI), which is then subjected to reaction with tributylstannyl derivative (VII) in toluene in the presence of Pd(PPh3)4 to furnish compound (VIII). Treatment of (VIII) with NaOH in refluxing MeOH gives indole (IX), which is converted into the final product by reduction with LiAlH4 in refluxing THF) and treatment with HCl for the formation of the corresponding hydrochloride salt. Alternatively, the target compound can be obtained as follows: treatment of (IV) with KH in ether and tert-butyllithium in pentane followed by reaction with N-methylpiperidinone (X) affords hydroxy derivative (XI), which is finally converted into the desired product.
【1】
Arora, J.; et al.; 5-Bicyclopiperidinetryptamine derivatives as selective 5-HT1D agonists. Soc Neurosci Abst 2000, 26, Part 1, Abst 145.14.
|
【2】
Slassi, A.; Edwards, L.; Meng, Q.; Rakhit, S. (NPS Allelix Corp.); 5-Cyclo indole cpds. as 5-HT1D receptor ligands. EP 0944595; JP 2001504501; WO 9823587 .
|
【3】
Rakhit, S.; Edwards, L.; Slassi, A.; Meng, Q. (NPS Allelix Corp.); 5-Cyclo indole cpds.. US 5998438 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13309 |
5-Bromo-1H-indole; 5-Bromoindole
|
10075-50-0 |
C8H6BrN |
详情 | 详情
|
(II) |
29841 |
Oxalyl chloride; 2-Chloro-2-oxoacetyl chloride
|
79-37-8 |
C2Cl2O2 |
详情 | 详情
|
(III) |
40926 |
2-(5-bromo-1H-indol-3-yl)-N,N-dimethyl-2-oxoacetamide
|
|
C12H11BrN2O2 |
详情 |
详情
|
(IV) |
49717 |
N-[2-(5-bromo-1H-indol-3-yl)ethyl]-N,N-dimethylamine; 2-(5-bromo-1H-indol-3-yl)-N,N-dimethyl-1-ethanamine
|
|
C12H15BrN2 |
详情 |
详情
|
(V) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(VI) |
49718 |
[5-bromo-3-[2-(dimethylamino)ethyl]-1H-indol-1-yl](phenyl)methanone
|
|
C19H19BrN2O |
详情 |
详情
|
(VII) |
49719 |
tert-butyl 4-(tributylstannyl)-3,6-dihydro-1(2H)-pyridinecarboxylate
|
|
C22H43NO2Sn |
详情 |
详情
|
(VIII) |
49720 |
tert-butyl 4-[1-benzoyl-3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-3,6-dihydro-1(2H)-pyridinecarboxylate
|
|
C29H35N3O3 |
详情 |
详情
|
(IX) |
49721 |
tert-butyl 4-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-3,6-dihydro-1(2H)-pyridinecarboxylate
|
|
C22H31N3O2 |
详情 |
详情
|
(X) |
10919 |
1-Methyl-4-piperidone; 1-Methyltetrahydro-4(1H)-pyridinone; N-Methyl-4-piperidone;1-methylpiperidin-4-one |
1445-73-4 |
C6H11NO |
详情 | 详情
|
(XI) |
49722 |
4-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-1-methyl-4-piperidinol
|
|
C18H27N3O |
详情 |
详情
|
合成路线55
该中间体在本合成路线中的序号:
(IX) Friedel Crafts acylation of methyl 2-methylazulene-1-carboxylate (I) with benzoyl chloride (II) and AlCl3 yielded the benzoylazulene (III). Subsequent saponification of the ester function with NaOH, followed by decarboxylation of the resulting acid (IV) using p-TsOH in boiling benzene provided (V). Mannich reaction of (V) with bis(dimethylamino)methane and paraformaldehyde produced amine (VI), which was quaternized with MeI to furnish the ammonium salt (VII). This was displaced by ethanolic KCN to give nitrile (VIII). Thioamide (IX) was then obtained by reaction of (VIII) with thioacetamide and HCl. Finally, the thiazole ring was constructed by cyclization of (IX) with bromoacetone.
【1】
Tomiyama, T.; Kasai, R.; Takeuchi, S.; Onkura, Y.; Benzoylazulene derivatives as selective cyclooxygenase-2 inhibitors. 216th ACS Natl Meet (Aug. 23-27, Boston) 1998, Abst MEDI 170.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22157 |
methyl 2-methyl-1-azulenecarboxylate
|
|
C13H12O2 |
详情 |
详情
|
(III) |
22159 |
methyl 3-benzoyl-2-methyl-1-azulenecarboxylate
|
|
C20H16O3 |
详情 |
详情
|
(IV) |
22160 |
3-benzoyl-2-methyl-1-azulenecarboxylic acid
|
|
C19H14O3 |
详情 |
详情
|
(V) |
22161 |
(2-methyl-1-azulenyl)(phenyl)methanone
|
|
C18H14O |
详情 |
详情
|
(VI) |
22162 |
[3-[(dimethylamino)methyl]-2-methyl-1-azulenyl](phenyl)methanone
|
|
C21H21NO |
详情 |
详情
|
(VII) |
22163 |
[2-methyl-3-[(trimethyl-lambda(5)-azanyl)methyl]-1-azulenyl](phenyl)methanone
|
|
C22H25NO |
详情 |
详情
|
(VIII) |
22164 |
2-(3-benzoyl-2-methyl-1-azulenyl)acetonitrile
|
|
C20H15NO |
详情 |
详情
|
(IX) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(IX) |
22165 |
2-(3-benzoyl-2-methyl-1-azulenyl)ethanethioamide
|
|
C20H17NOS |
详情 |
详情
|
合成路线56
该中间体在本合成路线中的序号:
Alkylation of aminotetralin (I) with bromoacetonitrile in boiling acetone gave cyanomethyl compound (II). This was subsequently reduced to diamine (III) using LiAlH4. Condensation of (III) with benzoyl chloride under Schotten-Baumann conditions then yielded the corresponding benzamide.
【1】
Homan, E.J.; Copinga, S.; Elfström, L.; van der Veen, T.; Hallema, J.-P.; Mohell, N.; Unelius, L.; Johansson, R.; Wikström, H.V.; Grol, C.J.; 2-Aminotetralin-derived substituted benzamides with mixed dopamine D2, D3, and serotonin 5-HT1A receptor binding properties: A novel class of potential atypical antipsychotic agents. Bioorg Med Chem 1998, 6, 11, 2111. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
|
31883 |
2-bromoacetonitrile
|
590-17-0 |
C2H2BrN |
详情 | 详情
|
(I) |
14648 |
N-(5-methoxy-1,2,3,4-tetrahydro-2-naphthalenyl)-N-propylamine; 5-methoxy-N-propyl-1,2,3,4-tetrahydro-2-naphthalenamine
|
|
C14H21NO |
详情 |
详情
|
(II) |
27938 |
2-[(5-methoxy-1,2,3,4-tetrahydro-2-naphthalenyl)(propyl)amino]acetonitrile
|
|
C16H22N2O |
详情 |
详情
|
(III) |
27939 |
N-(2-aminoethyl)-N-(5-methoxy-1,2,3,4-tetrahydro-2-naphthalenyl)-N-propylamine
|
|
C16H26N2O |
详情 |
详情
|
合成路线57
该中间体在本合成路线中的序号:
(II) The acylation of 3-amino-2,2-dimethyl-5-phenylpentanoic acid (I) with benzoyl chloride (II) in pyridine gives the corresponding amide (III), which is finally converted into the target anhydride by reaction with bromo-tris-pyrrolidino-phosphonium hexafluorophosphate (PyBroP) and triethylamine in dichloromethane.
【1】
Iijima, K.; Hayashi, Y.; Katada, J.; Symmetrical anhydride-type serine protease inhibitors: Structure-activity relationship studies of human chymase inhibitors. Bioorg Med Chem Lett 1999, 9, 3, 413.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
28656 |
3-amino-2,2-dimethyl-5-phenylpentanoic acid
|
|
C13H19NO2 |
详情 |
详情
|
(II) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(III) |
28657 |
3-(benzoylamino)-2,2-dimethyl-5-phenylpentanoic acid
|
|
C20H23NO3 |
详情 |
详情
|
合成路线58
该中间体在本合成路线中的序号:
(XI) The protection of 3-bromo-1-propanol (I) with dihydropyran (DHP) and p-toluenesulfonic acid gives the tetrahydropyranyl ether (II), which is condensed with 3,4-dichlorophenylacetonitrile (III) by means of NaH in THF yielding the pentanenitrile (IV). The condensation of (IV) with ethyl 3-bromopropionate (V) by means of potassium hexamethyldisylazide (KHMDS) in THF affords the heptanoate (VI), which is reductocyclized with H2 over RaNi in ethanol/aq. NH4OH affording the piperidone (VII). The reduction of (VII) by means of LiAlH4 in THF gives the piperidine (VIII), which is deprotected with HCl in ethyl ether yielding the racemic propanol (IX). The optical resolution of (IX) by means of (+)-camphorsulfonic acid in isopropanol affords the desired enantiomer (X), which is acylated with benzoyl chloride (XI) and DIEA in dichloromethane providing the benzoylpiperidine (XII). The reaction of (XII) with methanesulfonyl chloride and triethylamine gives the mesylate (XIII), which is treated with KI in refluxing acetone to yield the 3-iodopropyl derivative (XIV). Finally, (XIV) is condensed with 4-hydroxy-4-phenylpiperidine (XV) by means of KHCO3 in hot acetonitrile.
The intermediate 4-hydroxy-4-phenylpiperidine (XV) has been obtained as follows: The reaction of 1-benzyl-4-piperidone (XVI) with phenyllithium in THF gives 1-benzyl-4-hydroxy-4-phenylpiperidine (XVII), which is then debenzy-lated by hydrogenation with H2.
【1】
Kuo, B.-S.; Lee, H.T.; Roth, B.D.; Chung, F.-Z.; Atherton, J.; Chen, M.H.; Syntheses and biological activities of chiral piperidines-tachykinin NK3 antagonists. Acta Pharm Sin 1999, 20, 3, 283.
|
【2】
Chen, M.H.G.; Lee, H.T.; Chung, F.-Z. (Pfizer Inc.); 3-Alkyl-3-phenyl-piperidines. WO 9811090 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12573 |
3-Bromo-1-propanol; 3-Bromopropanol
|
627-18-9 |
C3H7BrO |
详情 | 详情
|
(II) |
29460 |
2-(4-bromobutoxy)tetrahydro-2H-pyran; 4-bromobutyl tetrahydro-2H-pyran-2-yl ether
|
|
C9H17BrO2 |
详情 |
详情
|
(III) |
26935 |
2-(3,4-dichlorophenyl)acetonitrile
|
3218-49-3 |
C8H5Cl2N |
详情 | 详情
|
(IV) |
29461 |
2-(3,4-dichlorophenyl)-6-(tetrahydro-2H-pyran-2-yloxy)hexanenitrile
|
|
C17H21Cl2NO2 |
详情 |
详情
|
(V) |
29132 |
ethyl 3-bromopropanoate
|
539-74-2 |
C5H9BrO2 |
详情 | 详情
|
(VI) |
29462 |
ethyl 4-cyano-4-(3,4-dichlorophenyl)-8-(tetrahydro-2H-pyran-2-yloxy)octanoate
|
|
C22H29Cl2NO4 |
详情 |
详情
|
(VII) |
29463 |
5-(3,4-dichlorophenyl)-5-[4-(tetrahydro-2H-pyran-2-yloxy)butyl]-2-piperidinone
|
|
C20H27Cl2NO3 |
详情 |
详情
|
(VIII) |
29464 |
3-(3,4-dichlorophenyl)-3-[4-(tetrahydro-2H-pyran-2-yloxy)butyl]piperidine; 4-[3-(3,4-dichlorophenyl)-3-piperidinyl]butyl tetrahydro-2H-pyran-2-yl ether
|
|
C20H29Cl2NO2 |
详情 |
详情
|
(IX) |
29465 |
3-[3-(3,4-dichlorophenyl)-3-piperidinyl]-1-propanol
|
|
C14H19Cl2NO |
详情 |
详情
|
(X) |
29466 |
3-[(3S)-3-(3,4-dichlorophenyl)piperidinyl]-1-propanol
|
|
C14H19Cl2NO |
详情 |
详情
|
(XI) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(XII) |
29467 |
[(3S)-3-(3,4-dichlorophenyl)-3-(3-hydroxypropyl)piperidinyl](phenyl)methanone
|
|
C21H23Cl2NO2 |
详情 |
详情
|
(XIII) |
29468 |
3-[(3S)-1-benzoyl-3-(3,4-dichlorophenyl)piperidinyl]propyl methanesulfonate
|
|
C22H25Cl2NO4S |
详情 |
详情
|
(XIV) |
29469 |
[(3S)-3-(3,4-dichlorophenyl)-3-(3-iodopropyl)piperidinyl](phenyl)methanone
|
|
C21H22Cl2INO |
详情 |
详情
|
(XV) |
28021 |
4-phenyl-4-piperidinol; 4-Hydroxy-4-phenylpiperidine; 4-(4-Phenyl)-4-hydroxypiperidine
|
40807-61-2 |
C11H15NO |
详情 | 详情
|
(XVI) |
15720 |
1-benzyltetrahydro-4(1H)-pyridinone; 1-Benzyl-4-piperidone; N-Benzyl-4-piperidone; 1-(benzyl)-4-piperidinone; 1-benzylpiperidin-4-one; 1-(benzyl)piperidin-4-one
|
3612-20-2 |
C12H15NO |
详情 | 详情
|
(XVII) |
24014 |
Phenyllithium
|
591-51-5 |
C6H5Li |
详情 | 详情
|
(XVIII) |
29470 |
1-benzyl-4-phenyl-4-piperidinol
|
|
C18H21NO |
详情 |
详情
|
合成路线59
该中间体在本合成路线中的序号:
(VIII) The acylation of 5-methoxy-1,2,3,4-tetrahydronaphthalene-2-(R)-amine (I) with propionyl chloride (II) and NaOH in dichloromethane/water gives the corresponding amide (III), which is reduced with LiAlH4 in refluxing THF yielding the corresponding secondary amine (IV). The alkylation of (IV) with bromoacetonitrile (V) by means of K2CO3 in refluxing acetone affords the expected tertiary amine (VI), which is reduced with LiAlH4 in refluxing THF providing the ethylenediamine (VII). Finally, this compound is benzoylated with benzoyl chloride and NaOH in dichloromethane/water.
【1】
Homan, E.J.; Grol, C.J.; Unelius, L.; Wilkstrom, H.V.; Copinga, S.; Jackson, D.M.; Synthesis and pharmacology of the enantiomers of the potential atypical antipsychotic agents 5-OMe-BPAT and 5-OMe-(2,6-di-OMe)-BPAT. Bioorg Med Chem 1999, 7, 7, 1263.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
31886 |
(2R)-5-methoxy-1,2,3,4-tetrahydro-2-naphthalenamine; (2R)-5-methoxy-1,2,3,4-tetrahydro-2-naphthalenylamine
|
|
C11H15NO |
详情 |
详情
|
(II) |
15967 |
propanoyl chloride; propionyl chloride
|
79-03-8 |
C3H5ClO |
详情 | 详情
|
(III) |
31882 |
N-[(2R)-5-methoxy-1,2,3,4-tetrahydro-2-naphthalenyl]propanamide; N-[(2R)-5-methoxy-1,2,3,4-tetrahydro-2-naphthalenyl]propanamide
|
|
C14H19NO2 |
详情 |
详情
|
(IV) |
14649 |
(2S)-5-methoxy-N-propyl-1,2,3,4-tetrahydro-2-naphthalenamine; N-[(2S)-5-methoxy-1,2,3,4-tetrahydro-2-naphthalenyl]-N-propylamine
|
|
C14H21NO |
详情 |
详情
|
(V) |
31883 |
2-bromoacetonitrile
|
590-17-0 |
C2H2BrN |
详情 | 详情
|
(VI) |
31884 |
2-[[(2R)-5-methoxy-1,2,3,4-tetrahydro-2-naphthalenyl](propyl)amino]acetonitrile
|
|
C16H22N2O |
详情 |
详情
|
(VII) |
31885 |
N(1)-[(2R)-5-methoxy-1,2,3,4-tetrahydro-2-naphthalenyl]-N(1)-propyl-1,2-ethanediamine; N-(2-aminoethyl)-N-[(2R)-5-methoxy-1,2,3,4-tetrahydro-2-naphthalenyl]-N-propylamine
|
|
C16H26N2O |
详情 |
详情
|
(VIII) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
合成路线60
该中间体在本合成路线中的序号:
(VII) Demethylation of compound (XI) by means of BBr3 in refluxing dichloromethane gives 5-hydroxytetralinyl derivative (XII), which is then condensed with bromoacetic acid ethyl ester (XIII) by means of K2CO3 in DMF or acetonitrile to furnish (ethoxycarbonylmethoxy)tetraline derivative (XIV). Finally, the target product is obtained by saponification of the ethyl ester group of (XIV) by means of NaOH in 1,2-dimethoxyethane.
【1】
Wenzel, T.; Nair, V.; Self-complementary oligodeoxyribonucleotides incorporating L-related isodeoxynucleosides: Synthesis, physical characterization, enzymology, and CD studies. Bioconjugate Chem 1998, 9, 6, 683.
|
【2】
Nair, V.; Taktakishvili, M.; Pommier, Y.; Neamati, N.; Recognition and inhibition of HIV integrase by a novel dinucleotide. Bioorg Med Chem Lett 2000, 10, 3, 249.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
46810 |
(2R,3S,4S)-2-(hydroxymethyl)tetrahydro-3,4-furandiol
|
|
C5H10O4 |
详情 |
详情
|
(II) |
46811 |
(2R,3S,4S)-2-([[tert-butyl(diphenyl)silyl]oxy]methyl)tetrahydro-3,4-furandiol
|
|
C21H28O4Si |
详情 |
详情
|
(III) |
46812 |
(2R,3R,4S)-2-([[tert-butyl(diphenyl)silyl]oxy]methyl)-4-[[methyl(dimethylene)-lambda(6)-sulfanyl]oxy]tetrahydro-3-furanol
|
|
C24H34O4SSi |
详情 |
详情
|
(IV) |
46813 |
tert-butyl(diphenyl)silyl ((2R,3R,4S)-3-[[tert-butyl(diphenyl)silyl]oxy]-4-[[methyl(dimethylene)-lambda(6)-sulfanyl]oxy]tetrahydro-2-furanyl)methyl ether; tert-butyl[((2R,3R,4S)-2-([[tert-butyl(diphenyl)silyl]oxy]methyl)-4-[[methyl(dimethylene)-lambda(6)-sulfanyl]oxy]tetrahydro-3-furanyl)oxy]diphenylsilane |
|
C40H52O4SSi2 |
详情 |
详情
|
(V) |
10343 |
9H-Purin-6-amine; 9H-Purin-6-ylamine; Adenine
|
73-24-5 |
C5H5N5 |
详情 | 详情
|
(VI) |
46814 |
(2R,3S,4R)-4-(6-amino-9H-purin-9-yl)-2-(hydroxymethyl)tetrahydro-3-furanol
|
|
C10H13N5O3 |
详情 |
详情
|
(VII) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(VIII) |
46815 |
N-[9-[(3R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydro-3-furanyl]-9H-purin-6-yl]benzamide
|
|
C17H17N5O4 |
详情 |
详情
|
(IX) |
46816 |
N-[9-((3R,4S,5R)-5-[[bis(4-methoxyphenyl)(phenyl)methoxy]methyl]-4-hydroxytetrahydro-3-furanyl)-9H-purin-6-yl]benzamide
|
|
C38H35N5O6 |
详情 |
详情
|
(X) |
46817 |
sodium [((2R,3S,4R)-4-[6-(benzoylamino)-9H-purin-9-yl]-2-[[bis(4-methoxyphenyl)(phenyl)methoxy]methyl]tetrahydro-3-furanyl)oxy](2-chlorophenoxy)oxophosphoranolate
|
|
C44H38ClN5NaO9P |
详情 |
详情
|
(XI) |
46818 |
(2R,3S,5R)-5-[4-(benzoylamino)-2-oxo-1(2H)-pyrimidinyl]-2-(hydroxymethyl)tetrahydro-3-furanyl acetate
|
|
C18H19N3O6 |
详情 |
详情
|
(XII) |
46819 |
(2R,3S,5R)-5-[4-(benzoylamino)-2-oxo-1(2H)-pyrimidinyl]-2-([[[((2R,3S,4R)-4-[6-(benzoylamino)-9H-purin-9-yl]-2-[[bis(4-methoxyphenyl)(phenyl)methoxy]methyl]tetrahydro-3-furanyl)oxy](2-chlorophenoxy)phosphoryl]oxy]methyl)tetrahydro-3-furanyl acetate
|
|
C62H56ClN8O14P |
详情 |
详情
|
(XIII) |
46820 |
(2R,3S,5R)-5-[4-(benzoylamino)-2-oxo-1(2H)-pyrimidinyl]-2-([[[[(2R,3S,4R)-4-[6-(benzoylamino)-9H-purin-9-yl]-2-(hydroxymethyl)tetrahydro-3-furanyl]oxy](2-chlorophenoxy)phosphoryl]oxy]methyl)tetrahydro-3-furanyl acetate
|
|
C41H38ClN8O12P |
详情 |
详情
|
(XIV) |
46821 |
cyanomethyl dihydrogen phosphate
|
|
C2H4NO4P |
详情 |
详情
|
合成路线61
该中间体在本合成路线中的序号:
(IV) Protection of 5-methoxyindole (I) with benzenesulfonyl chloride (II) in the presence of NaH affords the N-sulfonyl indole (III). Acylation of the 2-lithio derivative of (III) with benzoyl chloride (IV) gives rise to ketone (V). Finally, removal of the phenylsulfonyl protecting group of (V) is achieved by either basic hydrolysis or by treatment with tetrabutylammonium fluoride.
【1】
Hufsky, H.; Pongratz, H.; Mahboobi, S.; et al.; Synthetic 2-aroylindole derivatives as a new class of potent tubulin-inhibitory, antimitotic agents. J Med Chem 2001, 44, 26, 4535.
|
【2】
Teller, S.; Pongratz, H.; Mahboobi, S.; et al.; Bis(1H-2-indolyl) methanones as a novel class of inhibitors of the platelet-derived growth factor receptor kinase. J Med Chem 2002, 45, 5, 1002.
|
【3】
Burger, A.; Mahboobi, S.; Pongratz, H.; Hufsky, H.; Böhmer, F.-D.; Beckers, T.; Klenner, T.; Baasner, S.; Frieser, M.; Hockemeyer, J.; Fiebig, H.-H. (Asta Medica AG); 2-Acyl indol derivs. and their use as anti-tumour agents. DE 10020852; WO 0182909 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
25902 |
1H-Indol-5-yl methyl ether; 5-Methoxy-1H-indole; 5-Methoxyindole
|
1006-94-6 |
C9H9NO |
详情 | 详情
|
(II) |
14713 |
benzenesulfonyl chloride
|
98-09-9 |
C6H5ClO2S |
详情 | 详情
|
(III) |
57928 |
5-methoxy-1-(phenylsulfonyl)-1H-indole; methyl 1-(phenylsulfonyl)-1H-indol-5-yl ether
|
|
C15H13NO3S |
详情 |
详情
|
(IV) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(V) |
57929 |
[5-methoxy-1-(phenylsulfonyl)-1H-indol-2-yl](phenyl)methanone
|
|
C22H17NO4S |
详情 |
详情
|
合成路线62
该中间体在本合成路线中的序号:
(B) Solid phase synthesis: Attachment of 8-Fmoc-3-carboxymethyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (I) to Wang resin by means of 2,6-dichlorobenzoyl chloride (A) in DMF in the presence of pyridine, followed by treatment with benzoyl chloride (B) in dichloromethane in the presence of pyridine, provides resin-anchored derivative (II). Treatment of resin (II) with piperidine in DMF allows Fmoc removal to yield deprotected piperidine derivative (III), which is then converted into the target compound by alkylation with 1-(bromomethyl)naphthalene (IV) by heating in DMSO in the presence of DIEA, followed by cleavage of the molecule from the resin by heating with NaOMe in THF/MeOH. Alternatively, the conversion of (III) into the desired compound can be achieved by reductive amination between resin (III) and aldehyde (V) by means of NaBH3CN in THF in the presence of HOAc to afford anchored derivative (VI), followed by cleavage from the resin by heating with NaOMe in THF/MeOH.
【1】
Watson, B.; Thomsen, C.; Hohlweg, R. (Novo Nordisk A/S); Novel 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes. EP 1080091; WO 9959997 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(A) |
25087 |
2,6-dichlorobenzoyl chloride
|
4659-45-4 |
C7H3Cl3O |
详情 | 详情
|
(I),(II) |
47322 |
2-[8-[(9H-fluoren-9-ylmethoxy)carbonyl]-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]acetic acid
|
|
C30H29N3O5 |
详情 |
详情
|
(III) |
47323 |
2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl)acetic acid
|
|
C15H19N3O3 |
详情 |
详情
|
(IV) |
47324 |
1-(bromomethyl)naphthalene
|
3163-27-7 |
C11H9Br |
详情 | 详情
|
(V) |
12314 |
1-Naphthaldehyde
|
66-77-3 |
C11H8O |
详情 | 详情
|
(VI) |
47325 |
2-[8-(1-naphthylmethyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]acetic acid
|
|
C26H27N3O3 |
详情 |
详情
|
合成路线63
该中间体在本合成路线中的序号:
(VIII) N-Protection of 4-aminophenylacetonitrile (I) with benzyl bromide (II) by means of K2CO3 and KI in DMF affords dibenzylamino derivative (III), which is then methylated by first treatment with lithium bis(trimethylsilyl)amide (LiN(SiMe3)2) followed by MeI in THF to provide propionitrile derivative (IV). Reduction of the cyano moiety of (IV) by means of borane methylsulfide (BH3.DMS) in refluxing THF, followed by treatment with HCl/MeOH in Et2O, yields propylamine hydrochloride (V), which is then allowed to react with isopropylsulfonyl chloride in CH2Cl2 in the presence of either DBU or Et3N to furnish isopropylsulfonamide derivative (VI). Hydrogenation of (VI) over Pd/C in EtOH in the presence of ammonium formate (NH4+COO-) allows benzyl removal to yield compound (VII), which is finally condensed with benzoyl chloride (VIII) by means of Et3N in CH2Cl2 to provide the target product.
Alternatively, protection of the sulfonamide group of derivative (VI) can be performed by means of Boc2O and DMAP. Then hydrogenation of (VI) over Pd/C in EtOH in the presence of ammonium formate (NH4+COO-) allows benzyl removal, yielding compound (IX). Finally, condensation of (IX) with benzoyl chloride (VIII) by means of Et3N in CH2Cl2 followed by Boc removal by means of TFA in CH2Cl2 leads to the desired compound.
【1】
Zarrinmayed, H.; et al.; [3H]N-2-(4-benzamido)phenyl)propyl-2-propanesulfonamide: A novel AMPA receptor potentiator and radioligand. J Med Chem 2001, 44, 3, 302.
|
【3】
Ornstein, P.L.; Jones, W.D.; Zarrinmayeh, H.; Zimmerman, D.M.; Arnold, M.B. (Eli Lilly and Company); N-Substd. sulfonamide derivs.. WO 0006537 .
|
【2】
Arnold, M.B.; Bleakman, D.; Simon, R.L.; Cantrell, B.E.; Ornstein, P.L.; McKennon, T.E.; Tizzano, J.P.; Bleisch, T.J.; Zimmerman, D.M.; Baker, S.R.; Smith, E.; Zarrinmayeh, H.; Matsumoto, K.; Escribano, A.M. (Eli Lilly and Company); Sulphonamide derivs.. EP 0860428; WO 9833496 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
48841 |
4-Aminobenzyl cyanide; 4-Aminophenylacetonitrile; p-Aminophenylacetonitrile
|
3544-25-0 |
C8H8N2 |
详情 | 详情
|
(II) |
12912 |
1-(Bromomethyl)benzene; Alpha-bromotoluene
|
100-39-0 |
C7H7Br |
详情 | 详情
|
(III) |
48842 |
2-[4-(dibenzylamino)phenyl]acetonitrile
|
|
C22H20N2 |
详情 |
详情
|
(IV) |
48843 |
2-[4-(dibenzylamino)phenyl]propanenitrile
|
|
C23H22N2 |
详情 |
详情
|
(V) |
48844 |
4-(2-amino-1-methylethyl)-N,N-dibenzylaniline; N-[4-(2-amino-1-methylethyl)phenyl]-N,N-dibenzylamine
|
|
C23H26N2 |
详情 |
详情
|
(VI) |
48845 |
N-[2-[4-(dibenzylamino)phenyl]propyl]-2-propanesulfonamide
|
|
C26H32N2O2S |
详情 |
详情
|
(VII) |
48846 |
N-[2-(4-aminophenyl)propyl]-2-propanesulfonamide
|
|
C12H20N2O2S |
详情 |
详情
|
(VIII) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(IX) |
48847 |
tert-butyl 2-(4-aminophenyl)propyl(isopropylsulfonyl)carbamate
|
|
C17H28N2O4S |
详情 |
详情
|
合成路线64
该中间体在本合成路线中的序号:
(XII) Acylation of phenylalanine (XI) with benzoyl chloride (XII) under Schotten-Baumann conditions produced the corresponding benzamide (XIII). The cyclization of benzoylphenylalanine (XIII) in the presence of acetic anhydride afforded oxazolone (XIV), which was then reacted with trifluoroacetic anhydride producing the trifluoromethyl ketone (XV). After ketone (XV) reduction to carbinol (XVI) with NaBH4, the acidic hydrolysis of the benzamido group of (XVI) yielded the amino alcohol (XVII) (1). Condensation of acid (X) with amine (XVII) using EDC and HOBt gave amide (XVIII). The hydroxyl group of (XVIII) was then oxidized to ketone (XIX) employing a modified Pfitzner-Moffatt oxidation. Finally, hydrogenolysis of the benzyloxycarbonyl group of (XIX) furnished the desired aminopyrimidinone.
【1】
Akahoshi, F.; Ashimori, A.; Yoshimura, T.; et al.; Non-peptidic inhibitors of human chymase. Synthesis, structure-activity relationships, and pharmacokinetic profiles of a series of 5-amino-6-oxo-1,6-dihydropyrimidine-containing trifluoromethyl ketones. Bioorg Med Chem 2001, 9, 2, 301. |
【2】
Akahoshi, F.; Yoshimura, T.; Eda, M.; Ashimori, A.; Fukuyama, H.; Nakajima, M.; Imada, T.; Okunishi, H.; Miyazaki, M. (Welfide Corporation); Heterocyclic amide cpds. and medicinal use of the same. EP 0826671; US 5948785; WO 9633974 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(X) |
49080 |
2-[5-[[(benzyloxy)carbonyl]amino]-2-(4-fluorophenyl)-6-oxo-1(6H)-pyrimidinyl]acetic acid
|
|
C20H16FN3O5 |
详情 |
详情
|
(XI) |
26219 |
Phenylalanine
|
150-30-1 |
C9H11NO2 |
详情 | 详情
|
(XII) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(XIII) |
49081 |
N-Benzoyl-DL-phenylalanine
|
2901-76-0 |
C16H15NO3 |
详情 | 详情
|
(XIV) |
49082 |
4-Benzyl-2-phenyl-2-oxazolin-5-one
|
5874-61-3 |
C16H13NO2 |
详情 | 详情
|
(XV) |
49083 |
N-(1-benzyl-3,3,3-trifluoro-2-oxopropyl)benzamide
|
|
C17H14F3NO2 |
详情 |
详情
|
(XVI) |
49084 |
N-(1-benzyl-3,3,3-trifluoro-2-hydroxypropyl)benzamide
|
|
C17H16F3NO2 |
详情 |
详情
|
(XVII) |
49085 |
3-amino-1,1,1-trifluoro-4-phenyl-2-butanol
|
|
C10H12F3NO |
详情 |
详情
|
(XVIII) |
49086 |
benzyl 1-[2-[(1-benzyl-3,3,3-trifluoro-2-hydroxypropyl)amino]-2-oxoethyl]-2-(4-fluorophenyl)-6-oxo-1,6-dihydro-5-pyrimidinylcarbamate
|
|
C30H26F4N4O5 |
详情 |
详情
|
(XIX) |
49087 |
benzyl 1-[2-[(1-benzyl-3,3,3-trifluoro-2-oxopropyl)amino]-2-oxoethyl]-2-(4-fluorophenyl)-6-oxo-1,6-dihydro-5-pyrimidinylcarbamate
|
|
C30H24F4N4O5 |
详情 |
详情
|
合成路线65
该中间体在本合成路线中的序号:
(A) Benclonidine has been synthesized by various routes:
1) Condensation of 1-benzoylimidazolidin-2-one (II) [obtained by reaction of imidazolidin-2-one (I) with benzoyl chloride (A)] and 2,6-dichloroaniline (III) in the presence of phosphoroxy chloride at elevated temperature yields title compound. (1)
2) Clonidine (IV) reacts with benzoylimidazole (V) in aprotic solvents to give directly benclonidine. (2)
3) 2,6-Dichlorophenylisocyanide dichloride (VI) and benzoylethylenediamine (VII) are condensed in the presence of an acid acceptor to give benclonidine. (2)
【1】
Franzmair, R.; Pittner, H. (Chemie Linz AG); AU 333749 .
|
【2】
Franzmair, R. (Chemie Linz AG); AU 339897 .
|
【3】
Koch, H.; Benclonidine. Drugs Fut 1984, 9, 6, 408.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(I) |
36228 |
2-imidazolidinone
|
120-93-4 |
C3H6N2O |
详情 | 详情
|
(II) |
60764 |
1-benzoyl-2-imidazolidinone
|
|
C10H10N2O2 |
详情 |
详情
|
(III) |
60765 |
2,6-dichloroaniline; 2,6-dichlorophenylamine
|
|
C6H5Cl2N |
详情 |
详情
|
(IV) |
60767 |
2,6-dichloro-N-(2-imidazolidinylidene)aniline; N-(2,6-dichlorophenyl)-N-(2-imidazolidinylidene)amine
|
|
C9H9Cl2N3 |
详情 |
详情
|
(V) |
60766 |
1H-imidazol-1-yl(phenyl)methanone
|
|
C10H8N2O |
详情 |
详情
|
(VI) |
60768 |
1,3-dichloro-2-[(dichloromethylene)amino]benzene
|
|
C7H3Cl4N |
详情 |
详情
|
(VII) |
60769 |
N-(2-aminoethyl)benzamide
|
|
C9H12N2O |
详情 |
详情
|
合成路线66
该中间体在本合成路线中的序号:
(I) Condensation of benzoyl chloride (I) with ammonium thiocyanate in boiling acetone produces benzoyl isothiocyanate (II). This is then coupled with the known 3-amino-5-phenyl-1,2,4-thiadiazole (III) to afford the N-benzoyl thiourea (IV) (1). Finally, hydrolysis of (IV) under alkaline conditions gives rise to the target thiadiazolyl thiourea
【1】
Kurzer, F.; 1,2,4-Thiadiazolylureas. A postcript to the oxidative cyclisation of thionoamidines. J Chem Soc - Perkins Trans I 1985, 2, 311.
|
【2】
Camden, J.B. (The Procter & Gamble Co.); Thiadiazolyl urea or thiourea derivs. for antiviral treatment. JP 2002540156; US 6258831; WO 0057878 .
|
【3】
Agyin, J.K. (The Procter & Gamble Co.); Process for the preparation of 1,2,4-thiadiazoles. US 6297384 .
|
【4】
Camden, J.B. (The Procter & Gamble Co.); Viral treatment. JP 2002540150; US 6245788; WO 0057869 .
|
【5】
Camden, J.B. (The Procter & Gamble Co.); Viral treatment. US 6340696 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(II) |
23530 |
benzoyl isothiocyanate
|
532-55-8 |
C8H5NOS |
详情 | 详情
|
(III) |
62354 |
|
|
C18H19N3O4 |
详情 |
详情
|
(IV) |
62358 |
N-benzoyl-N'-(5-phenyl-1,2,4-thiadiazol-3-yl)thiourea
|
|
C16H12N4OS2 |
详情 |
详情
|
合成路线67
该中间体在本合成路线中的序号:
(X) Intermediate (V) is prepared by treatment of ethyl β-D-thiogalactopyranoside (VII) with Bu2SnO in MeOH, followed by regioselective alkylation with triflate (VIII) in the presence of CsF in DME to afford ether (IX), which by subsequent esterification with benzoyl chloride (X) by means of pyridine and DMAP gives tribenzoate (XI). Coupling of thioglycoside (XI) with the acceptor alcohol (XII) in the presence of DMTST in CH2Cl2 yields adduct (XIII), which is then subjected to reductive acylation with orotic acid chloride (XIV) by means of PPh3 in CH2Cl2 to provide amide (XV). Finally, compound (XV) is debenzylated by hydrogenolysis with H2 over Pd/C in dioxane/H2O, followed by selective didebenzoylation by means of NaOMe in MeOH .
【1】
Magnani, J.L., Patton, J.T. Jr., Sarkar, A.K., Svarovsky, S.A., Ernst, B. (GlycoMimetics, Inc.). Heterobifunctional pan-selectin inhibitors. EP 1934236, EP 2264043, JP 2009507031, US 2007054870, US 7728117, WO 2007028050. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(V) |
68486 |
(2R)-2-(((2S,3S,4R,5R,6S)-2-(((1S,3R,5S)-5-((2-aminoethyl)carbamoyl)-3-(2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxamido)-2-(((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)cyclohexyl)oxy)-3-(benzoyloxy)-5-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)oxy)-3-cyclohexylpropanoic acid |
|
C41H55N3O19 |
详情 | 详情
|
(VII) |
68488 |
Ethyl 1-thio-β-D-galactopyranoside;Ethyl 1-deoxy-1-thio-β-D-galactopyranoside;(2S,3S,4R,5S,6R)-2-(ethylthio)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol;β-D-thiogalactopyranoside |
56245-60-4 |
C8H16O5S |
详情 | 详情
|
(VIII) |
68489 |
(R)-benzyl 3-cyclohexyl-2-(((trifluoromethyl)sulfonyl)oxy)propanoate |
|
C17H21F3O5S |
详情 | 详情
|
(IX) |
68490 |
(R)-benzyl 3-cyclohexyl-2-(((2S,3S,4R,5S,6R)-2-(ethylthio)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)oxy)propanoate |
|
C24H36O7S |
详情 | 详情
|
(X) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(XI) |
68495 |
(2S,3S,4R,5S,6R)-2-((benzoyloxy)methyl)-4-(((R)-1-(benzyloxy)-3-cyclohexyl-1-oxopropan-2-yl)oxy)-6-(ethylthio)tetrahydro-2H-pyran-3,5-diyl dibenzoate |
|
C45H48O10S |
详情 | 详情
|
(XII) |
68493 |
(1S,3S,4R,5R)-methyl 3-azido-5-hydroxy-4-(((2S,3S,4R,5S,6R)-3,4,5-tris(benzyloxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)cyclohexanecarboxylate |
|
C35H41N3O8 |
详情 | 详情
|
(XIII) |
68494 |
(2S,3S,4R,5S,6R)-2-(((2S,5S)-3-azido-5-(methoxycarbonyl)-2-(((2R,3R,4S,5S,6R)-3,4,5-tris(benzyloxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)cyclohexyl)oxy)-6-((benzoyloxy)methyl)-4-(((R)-1-(benzyloxy)-3-cyclohexyl-1-oxopropan-2-yl)oxy)tetrahydro-2H-pyran-3,5-diyl dibenzoate |
|
C78H83N3O18 |
详情 | 详情
|
(XIV) |
68491 |
orotic acid chloride;Orotoylchloride;Orotyl chloride;1,2,3,6-tetrahydro-2,6-dioxo-4-Pyrimidinecarbonylchloride |
3346-64-3 |
C5H3ClN2O3 |
详情 | 详情
|
(XV) |
68492 |
(2S,3S,4R,5S,6R)-2-((benzoyloxy)methyl)-4-(((R)-1-(benzyloxy)-3-cyclohexyl-1-oxopropan-2-yl)oxy)-6-(((2S,3R,5S)-3-(2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxamido)-5-(methoxycarbonyl)-2-(((2R,3R,4S,5S,6R)-3,4,5-tris(benzyloxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)cyclohexyl)oxy)tetrahydro-2H-pyran-3,5-diyl dibenzoate |
|
C83H87N3O21 |
详情 | 详情
|